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Importance:  A Mediterranean-style diet has been shown to be effective in 
improving a variety of disease outcomes, including metabolic risk factors. Such 
dietary patterns are complex and, thus it is currently unclear as to which 
components and intervention characteristics are more greatly associated with 
reducing metabolic syndrome risk.  
Objective: To obtain overall effect sizes for the metabolic risk factors (waist 
circumference, HDL cholesterol, triglycerides, fasting blood glucose, systolic 
blood pressure, and diastolic blood pressure) and explain the variability across 
the current literature based on study design, sample, and diet characteristics.   
Data Sources: Six electronic databases (PubMed, EMBASE, Web of Science, 
CINAHL, CAB Direct, and Agricola) were searched from inception until August 4, 
2014 using a comprehensive Boolean search strategy.   
Study Selection: Studies were included if pre- and post- intervention 
measurements of waist circumference were reported and the traditional 
Mediterranean-style diet was used as a dietary intervention. Data from 32 studies 
(N = 3,550) were included.   
Data Extraction and Synthesis: Independent researchers identified studies that 
met the inclusion criteria and coded methodological, participant, and intervention 
characteristics. 
Main Outcomes and Measures: Weighted mean effect size under random-
effects assumptions were obtained and modeled after pooling the individual 




Results: There were significant beneficial effects in favor of the traditional 
Mediterranean-style diet for waist circumference, triglycerides, fasting blood 
glucose, systolic blood pressure, and diastolic blood pressure (d+=-0.58, 95% CI 
-0.81 to -0.35; d+=-0.33, 95% CI -0.69 to -0.19; d+=-0.51, 95% CI -0.80 to -0.22; 
d+=-0.74, 95%CI -1.03 to -0.46; d+=-0.92, 95% CI -1.41 to -0.43, respectively). 
The Mediterranean-style diet was significantly beneficial when, in general the 
intervention period was longer in duration, the study was conducted in Europe, 
the study used a behavioral technique, and the study was conducted primarily 
using small groups.    
Conclusions and Relevance: The traditional Mediterranean-style diet had a 
significant beneficial effect on five of the six metabolic risk factors. This dietary 
pattern appears to be most successful in reducing metabolic risk when it is 
recommended for longer periods of time and is implemented using social 








 Metabolic syndrome is defined as a group of interrelated risk factors of 
metabolic origin that appear to directly promote the development of 
cardiovascular disease (CVD)1.  These metabolic risk factors are also associated 
with the development of type 2 diabetes mellitus1.  Underlying risk factors for 
metabolic syndrome include abdominal obesity, insulin resistance, physical 
inactivity, aging, hormonal imbalance, and genetic or ethnic predisposition1.  
Currently, lifestyle therapies such as diet modification and physical activity are 
first-line interventions to treat the metabolic risk factors1.  The traditional 
Mediterranean-style diet (MedSD) is well-known for its cardio-protective benefits2 
and should be considered for prevention and treatment of metabolic syndrome. 
The National Cholesterol Education Program’s Adult Treatment Panel III 
report (NCEP ATPIII)3 identified six components of metabolic syndrome that are 
related to CVD: 1) abdominal obesity, 2) atherogenic dyslipidemia, 3) elevated 
blood pressure, 4) insulin resistance, 5) proinflammatory state, and 6) 
protrhombotic state3.  According to the ATP III criteria, a diagnosis of metabolic 
syndrome can be made when three out of five of the following characteristics are 
present: 1) abdominal obesity characterized by waist circumference >102 cm for 
men and >88 cm for women, 2) triglycerides ≥150mg/dL, 3) HDL cholesterol <40 
mg/dL for men and <50 mg/dL for women, 4) blood pressure ≥130/≥85 mmHg, 
and 5) fasting glucose ≥110 mg/dL3.  Metabolic syndrome is a major health 




National Health and Nutrition Examination Survey (NHANES) suggest that 
according to the ATP III criteria approximately 34% of adults in the United States 
have metabolic syndrome4.  Males and females 40-59 years of age were about 
three times more likely as those 20-39 years of age to meet the criteria for 
metabolic syndrome4.  Males 60 years of age and older were four times as likely 
and females 60 years of age and older were more than six times as likely as the 
youngest age group (20-39 years of age) to meet the criteria for metabolic 
syndrome4.  With the increasing prevalence of metabolic syndrome, diet 
modification, particularly adherence to the traditional MedSD, should be 
considered as a lifestyle change. 
The MedSD refers to the dietary habits traditionally followed by people in 
the countries bordering the Mediterranean Sea2.  The traditional MedSD puts 
emphasis on an abundance of food from plant sources, a variety of minimally 
processed and locally grown foods, and olive oil as the principal source of fat5.  
This dietary pattern also includes daily consumption of low to moderate amounts 
of cheese and yogurt (low-fat and non-fat versions may be preferable), twice 
weekly consumption of fish and poultry, consumption of up to seven eggs per 
week, fresh fruit as dessert, red meat consumption limited to a few times a 
month, moderate consumption of wine (1 glass/day for women and 1-2 
glasses/day for men) and regular physical activity at a level which promotes 




The beneficial role of the MedSD with regard to overall mortality and other 
chronic diseases is well-established.  A 2010 meta-analysis of prospective 
studies found that adherence to the Mediterranean diet suggests significant 
protection against major chronic degenerative diseases, a significant reduction in 
death from any cause, a reduction in the incidence of cardio-and cerebro-
vascular diseases, reduction in the incidence of neoplastic diseases, and 
reduction of the incidence of neurodegenerative diseases2.  In addition, a 
secondary analysis of the PREDIMED6 trial concluded that an energy-
unrestricted Mediterranean diet may be useful in reducing the risks of central 
obesity and hyperglycemia in people at high risk of CVD7.  However, there is 
limited evidence on the effect of a traditional MedSD on metabolic risk factors.   
To our knowledge, only one meta-analysis has evaluated literature on the 
effects of a Mediterranean diet on metabolic syndrome to date8. This meta-
analysis included 35 clinical trials, 2 prospective studies, and 13 cross-sectional 
studies with a total of 534,906 participants and found an overall beneficial effect 
of the Mediterranean diet on reducing metabolic syndrome and its components in 
adults88.  Further, the Scientific Report of the 2015 Dietary Guidelines Advisory 
Council9 found dietary characteristics similar to that of a MedSD, including higher 
intake of vegetables, fruits, seafood, legumes, and nuts; moderate intake of 
alcohol (among adults); lower consumption of red and processed meat, and low 
intake of sugar-sweetened foods and drinks9, to have a positive effect on 




together, the findings from the meta-analysis by Kastorini et al.8 noted above and 
the 2015 Dietary Guidelines Advisory Council9 clearly support the positive effects 
of the MedSD on metabolic risk factors.  However, it is currently unclear which 
specific characteristics of these MedSD interventions greatly contribute to 
significant beneficial effects on the metabolic risk factors such as specific 
population, location, length of adherence to the MedSD and specific dietary 
components.  Analyzing particular moderators within the current evidence can 
allow for the development of population specific guidelines to enhance the 
beneficial effects of the MedSD as well as increase adherence to this dietary 
pattern.   
As mentioned above, CVD risk factors and metabolic syndrome are 
interrelated such that the diagnostic criteria defining metabolic syndrome 
encompasses a cluster of health outcomes related to CVD risk.  Several 
systematic reviews and meta-analyses published within the last 10 years that 
have focused on the MedSD and CVD risk outcomes have reported an overall 
beneficial effect of the MedSD in reducing CVD risk factors10.  Before evidenced-
based guidelines for CVD risk reduction can be put into practice, these meta-
analyses should undergo a formal evaluation of quality.  To address this issue, 
we recently conducted a review10 of methodological quality of systematic reviews 
and meta-analyses on the MedSD and CVD risk outcomes  using an established 
methodological quality scale (Assessment of Multiple Systematic Reviews11).  On 




maximum AMSTARMD score of 2010.  Four reviews satisfied at least 80% of the 
items possible, suggesting relatively high quality, 3 satisfied at least 45% of the 
items, suggesting moderate quality, and the other 13 satisfied less than 45% of 
the items, suggesting low quality10.  The data from this review suggest that 
current meta-analyses evaluating the effects of the MedSD on CVD risk do not 
fully comply with contemporary methodological quality standards.  This review 
provides evidence to support the need for high quality systematic reviews and 
meta-analyses on the MedSD and various health outcomes that comply with 
current methodological quality standards.   
Given the increasing prevalence of metabolic syndrome, the popularity 
and relevance of the MedSD, and the reported quality issues of current meta-
analyses that have focused on the MedSD, we were interested in evaluating the 
effects of the traditional MedSD on the following metabolic risk factors: 1) waist 
circumference, 2) HDL cholesterol, 3) triglycerides, 4) systolic blood pressure, 5) 
diastolic blood pressure, and 6) fasting blood glucose.  The purpose of this work 
was to conduct a high-quality meta-analysis to evaluate the relationship between 
the traditional MedSD and metabolic risk factors.  This study had three specific 
aims: 1) to obtain overall effect sizes for each outcome of interest (waist 
circumference, HDL cholesterol, triglycerides, systolic blood pressure, diastolic 
blood pressure, and fasting blood glucose), 2) to evaluate the 




the variability across the current literature on this topic using moderators based 
on study, sample, and diet characteristics.   
Our primary hypothesis is that effects for each outcome will favor the 
traditional MedSD against baseline (standardized mean difference, d≠0) with a 
null hypothesis that the traditional MedSD will have no impact on metabolic risk 
factors (d=0).  Our second hypothesis is that the studies will show large and 
significant variability based on the Q statistic and the I2 index.  Lastly, we 
hypothesized that the variability will be explained using moderators based on 
sample, diet and study characteristics.   
Methods 
Literature Search 
The data sources were obtained following the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses: The PRISMA Statement12 
guidelines.  Original research studies that were published regardless of 
publication type until August 4, 2014 were included.  Language was not 
restricted.  Six computer databases were searched: PubMed, EMBASE (via 
Scopus), Web of Science, CINAHL, Agricola, and CAB Direct.  A comprehensive 
literature search was conducted with the assistance of the University of 
Connecticut Health Sciences Librarian (JL) using combinations of Medical 
Subject Headings and other key words related to the aim of the study.  Examples 
of the key words include: “Mediterranean Diet”, “Mediterranean Style Diet”, 




circumference”, obese, obesity, “abdominal fat”, and “weight loss”.  The 
comprehensive search that was conducted for each database can be found in 
Appendix 1.  In addition to the electronic database search, all studies from 
Kastorini, et al.8 were screened and four studies overlap in both meta-analyses.  
The original search focused on obesity outcomes such as weight, BMI, and waist 
circumference.  With the current focus on metabolic risk factors, studies must 
report pre-and post-intervention data on waist circumference in order to be 
included in the analysis.  Manuscripts that met the following criteria were 
included: studies that had pre- and post-intervention measurements for at least 
waist circumference (any other metabolic risk factors were additional) and 
studies that focused on the Mediterranean diet as a whole dietary pattern.  
Studies that did not have pre- and post- intervention data on waist circumference, 
those that focused on particular components of the Mediterranean diet, such as 
only olive oil, those that included exercise in the intervention, and those that did 
not report the information in a way that would allow effect sizes to be calculated 
using the published information were excluded.  The relevance of studies was 
assessed by two independent researchers (MG and JS) with a hierarchical 
approach on the basis of title, abstract, and full manuscript.  The original search 
resulted in 1,269 abstracts with relevant key words.  After screening and hand-
searching articles, 32 articles (41 total comparisons) that used the traditional 
MedSD were included in analysis.  Refer to Figure 1 for the PRISMA figure of 




studies.  The screening form used by both coders can be found in Appendix 2.  
A list of excluded articles is available upon request.  
Data Extraction 
A comprehensive and detailed coding form and manual was created by a 
team of researchers comprised of registered dietitians, a biostatistician, and a 
physician.  The coding form includes approximately 330 variables for each study.  
Various characteristics were extracted from each study: 1) sample characteristics 
such as ethnicity, number and proportion of females, location of sample, and 
recruitment details, 2) intervention characteristics such as length of intervention, 
diet type, distribution of macronutrients, calorie intake, and participation in dietary 
counseling, and 3) study design characteristics such as number of interventions, 
type of control group, experimental conditions, and setting.  The coding form was 
pilot-tested by two independent researchers (MG and JS) and was reviewed by 
additional experts (JB, JK, AK, TBHM) before being finalized.   The coding form 
can be found in Appendix 3.  The coding manual is available upon request.  All 
32 studies were independently reviewed and coded by two researchers (MG and 
JS) and disagreements were solved by a third-party expert (TBHM).   
Risk of Bias 
 The Cochrane Collaboration’s tool for assessing risk of bias was used to 
assess risk of bias within individual studies13.  Raters score items with either a 
minus sign (“-“) indicating high risk of bias; a plus sign (“+”) indicating moderate 




parameter.  In accordance with these guidelines, we report descriptions of 
internal and external validity summary ratings categorically, converting these to 
numerical scores as necessary for the purpose of meta-analytic moderator 
analysis.   
 Methodological quality (MQ) rankings have been identified as an under-
analyzed element of the data reported in meta-analyses14.  In this meta-analysis, 
MQ ratings based on the Cochrane risk of bias scale were entered as one or 
more possible moderators into the mixed-effects metaregression models.   
Statistical Analysis  
All descriptive statistics for the included articles were calculated using 
SAS Version 9.415.  All code for this analysis can be found in Appendix 4.  Inter-
rater reliability was calculated for all continuous and categorical variables using 
IBM SPSS Statistics Version 2216.  The Kappa (κ) coefficient was used to 
calculate categorical agreement17 (kappa=0.94, 96.9% agreement) and 
Pearson’s correlation coefficient was used to calculate continuous agreement18 
(r=1).  We tested for asymmetries by using the Begg19, Egger20, and trim-and-fill21 
statistical tests as well as the funnel plot 22 graphical technique.  Publication bias 
and the remaining statistical tests were calculated using R version 3.1.223 
“metafor” package24.  All code for this analysis can be found in Appendix 5. 
Effect sizes (ESs) were calculated for each outcome by calculating the 
standardized mean change25 for each sample.  The standardized mean change, 




divided by the pre-test standard deviation25.  The standardized mean change 
allows results from several kinds of designs to be compared or combined directly, 
eliminating the need to omit studies because of design differences25,26 (i.e., 
between versus within-in group).  The effect size index, d, follows a normal 
distribution with a range from negative infinity to positive infinity with zero as the 
null value.  Following Cohen’s classification the magnitude of  the standardized d  
value can be interpreted as 0.25, 0.5, and 0.8 for small, median, and large effects 
on the outcomes of interest17.  However, ESs should be interpreted based on 
their clinical impact depending on the specific outcome and area of research.  
ESs were calculated using an effect size coding calculator created by Huedo-
Medina, et al.27.  This calculator uses a factor that controls for small sample 
size28.   
The data extracted to obtain the individual ESs could be means and 
standard deviations, F-ANOVA, t-test, or mean and standard deviation change.  
To uphold the assumption of independence, each outcome was analyzed 
independently when multiple outcomes were reported from the same study.  
Twenty four studies report at least three outcomes with the most common 
outcomes being waist circumference, HDL cholesterol, and triglycerides; fifteen 
studies reported all six outcomes of interest.  A multivariate approach for multiple 
subsamples per study was not followed because no more than five comparisons 
were available per study.  Multiple ESs were obtained from the same study when 




studies had subsamples based on gender31,32, three studies had multiple 
subsamples for participant characteristics33,34,35, and one study had subsamples 
based on different distributions of macronutrients throughout the day36. 
Weighted mean effect size by the inverse of the variance of each study  
was calculated across all studies under random- and fixed-effects assumptions37.  
The random effects model assumes that the data is coming from different 
populations and accounts for within and between-study variance37.  The fixed 
effects model assumes that all effect sizes are from the same population and 
accounts for only within study variance37.  To test for heterogeneity, Cochran’s Q 
and I2 were calculated.  Q tests for significance of heterogeneity38 whereas I2 
calculates the magnitude of heterogeneity with a range from 0%-100%39.  To 
evaluate the sources of heterogeneity of the ESs, moderator analysis using 
weighted mixed-effects models with maximum likelihood estimation of the 
random-effects weights was performed testing each variable for study, 
intervention, and participant characteristics independently.  Moderator analysis 
was conducted by using the “mods” command in R.  The moving constant 
technique40 was used to produce estimates of the ES (d+) at meaningful levels of 
the moderators and their CIs at different levels of interest.  This technique was 
used to demonstrate results at the maximum and minimum values of significant 
moderators.  Two-sided statistical significance was p<0.05.  Finally, clinical units 
of measures were included by transforming arithmetically the standardized ES to 





Analysis of 32 reports shows that out of 3,550 participants, 74% were 
female with a mean age of 47.19 (SD=11.29).  A majority of the studies were 
conducted in Europe (53.56%) and published in English (97.97%).  The included 
studies varied in design: 37.72% had a non-MedSD comparison group, 10.26% 
of studies were crossover design, and 33.9% were pre-/post-test only design.  
The mean publication year was 2010 (SD=2.64) with an 11 year range from 
2003-2014.  The mean intervention length was 32.4 (SD=45.34) weeks with a 
range from four to 208 weeks.  No significant asymmetries were found using any 
of the statistical tests or the graphical funnel plot.  A summary of the publication 
bias results can be found in Table 2.   
Effect Sizes 
The traditional MedSD was found to have a significant beneficial effect on 
five out of six outcomes of interest.  Overall ESs under random-effects 
assumptions indicate that the traditional MedSD has a significant overall effect on 
waist circumference, triglycerides, fasting blood glucose, systolic blood pressure, 
and diastolic blood pressure (d+=-0.58, 95%CI -0.81 to -0.35; d+=-0.33, 95%CI -
0.69 to -0.19; d+=-0.51, 95%CI -0.80 to -0.22; d+=-0.74, 95%CI -1.03 to -0.46; 
d+=-0.92, 95%CI -1.41 to -0.43, respectively).  The null hypothesis regarding 
significant effects on metabolic risk factors was rejected for a majority of the 
outcomes of interest.  There was not enough evidence to reject the null 




heterogeneity between studies with I2 ranging from 93.01%-98.23%.  There was 
enough empirical evidence to reject the null hypothesis for variability between 
studies.  Refer to Table 3 for the overall effect sizes and homogeneity for each of 
the metabolic risk factors.  Please refer to Figures 2-7 for the forest plots for 
each of the metabolic risk factors.   
 
Moderator Analysis 
Moderator analysis was conducted in order to use the descriptive 
variables to account for some of the variability between studies.  Studies included 
in this meta-analysis varied in some characteristics in regard to study design, 
population, and dietary intervention.  In regards to study characteristics, 
marginally significant associations were found for study region ( =2.9%, 
p=0.23;  =16.69%, p=0.08; 	 =4.42%, p=0.28; 
	 = 3.5%, p=0.33 for 
waist circumference, HDL cholesterol, triglycerides, and fasting blood glucose, 
respectively).  Studies conducted in Europe showed significant beneficial effects 
from the traditional MedSD intervention on four of the metabolic risk factors (dwc= 
-0.82, 95%CI: -1.12, -0.51; dHDL=0.55, 95%CI: 0.21, 0.89; dTG= -0.71, 95%CI: -
1.08, -0.35; dFBG= -0.75, 95%CI: -1.15, -0.35 for waist circumference, HDL 
cholesterol, triglycerides, and fasting blood glucose, respectively), whereas those 
studies conducted in the United States did not result in significant effect sizes 




95%CI:-0.75, 0.48; dFBG=-0.18, 95%CI:-0.96, 0.60 for waist circumference, HDL 
cholesterol, triglycerides, and fasting blood glucose, respectively).   
Significant associations were found for study design for five of the six 




	 = 32.81%, p=0.0015;  = 29.09%, p<0.001 for 
waist circumference, HDL cholesterol, triglycerides, fasting blood glucose, and 
systolic blood pressure, respectively).  Studies using a comparison intervention 
group design (i.e., a different type of diet) had more beneficial significant effect 
sizes (dwc=-1.14, 95%CI:-1.51, -0.77; dHDL=0.79, 95%CI:0.46, 1.13; dTG=-0.99, 
95%CI:-1.37, -0.06; dFBG= -1.13, 95%CI:-1.58, -0.67; dSBP=-1.36, 95%CI:-1.84, -
0.88; dDBP=-1.32, 95%CI:-2.27, -0.36 for waist circumference, HDL cholesterol, 
triglycerides, fasting blood glucose, systolic blood pressure, and diastolic blood 
pressure, respectively) compared to those studies using a traditional pre-/post- 
design or a crossover design (dwc= -0.34, 95%CI: -0.58, -0.09;  dSBP=-
0.51,95%CI:-0.79,-0.23; dDBP=-0.77, 95%CI:-1.34,-0.19 for waist circumference, 
systolic blood pressure, and diastolic blood pressure, respectively).   
Studies with a higher Impact per Publication (IPP) value showed more 
significant beneficial effects for four out of six of the metabolic risk factors 
( =45.1%, p<0.0001;  =37.03%, p=0.0015; 	 =23.74%, p=0.014; 
	 = 
39.48%, p=0.0005 for waist circumference, HDL cholesterol, triglycerides, and 
fasting blood glucose, respectively).  A predictive model was performed in order 




and 16.104).  There were significant associations for IPP value for four outcomes 
of interest (Bwc= -0.11, p<0.0001; BHDL=0.07, p=0.002; BTG=-0.06, p=0.01; BFBG=-
0.08, p=0.0005 for waist circumference, HDL cholesterol, triglycerides, fasting 
blood glucose, respectively).  In the predictive model, the maximum IPP score 
resulted in more significant beneficial effect sizes than the minimum IPP score. 
The length of the intervention (in weeks) significantly explains between 
26.2% and 53.32% of the variability between studies for the following outcomes: 
waist circumference, HDL cholesterol, triglycerides, fasting blood glucose and 
systolic blood pressure.  The meta-regression plots for these analyses are 
represented in Figures 8-13.  A predictive model was performed in order to 
determine the magnitude of effect for the minimum and maximum lengths of 
intervention (4 and 208 weeks).  There was a significant association for length of 
intervention for all six outcomes of interest (Bwc=-0.01, p<0.0001; BHDL=0.009, 
p<0.0001; BTG=-0.008, p=0.006; BFBG=-0.009, p<0.001; BSBP=-0.007, p=0.005; 
BDBP=-0.009, p=0.09 for waist circumference, HDL cholesterol, triglycerides, 
fasting blood glucose, systolic blood pressure, and diastolic blood pressure, 
respectively).  The longer the length of the intervention, the more significant the 
beneficial effect in favor of the traditional MedSD.  These results are presented in 
Table 4.   
Additional significant or marginally significant intervention characteristics 
include the use of a behavioral technique and dietary interventions conducted 




during the intervention (i.e., positive reinforcement or self-monitoring) explained 
between 2.26% and 14.18% of the variability between studies.  The use of a 
behavioral technique resulted in marginally significant or significant beneficial 
effects in all of the outcomes of interest (dwc= -0.73, 95%CI:-1.08, -0.38; 
dHDL=0.50, 95%CI: 0.12, 0.89; dTG= -0.79, 95%CI:-1.21, -0.37; dFBG= -0.88, 
95%CI: -1.34, -0.43; dSBP= -1.12, 95%CI: -1.56, -0.68; dDBP=-1.63, 95%CI: -2.35, -
0.85 for waist circumference, HDL cholesterol, triglycerides, fasting blood 
glucose, systolic blood pressure, and diastolic blood pressure, respectively) 
compared to the effects when there was no behavioral technique used (dwc = -
0.41, 95%CI:-0.71, -0.11;  dHDL=-0.08, 95%CI:-0.42, 0.25; dTG= -0.27, 95%CI:-
0.59, 0.60; dFBG= -0.31, 95%CI: -0.69, 0.07; dSBP=-0.54, 95%CI:-0.92,-0.17; 
dDBP=-0.53, 95%CI: -1.16, 0.11 for waist circumference, HDL cholesterol, 
triglycerides, fasting blood glucose, systolic blood pressure, and diastolic blood 
pressure, respectively).  
 The level of intervention or supervision during the study (i.e., primarily 
one-on-one or small groups) resulted in significant associations ( =16.12%, 
p=0.014;  =22.31%, p=0.012; 	 =25.64%, p=0.006; 
	 =19.01%, 
p=0.004;  =30.73%, p=0.004) for waist circumference, HDL cholesterol, 
triglycerides, fasting blood glucose, systolic blood pressure, and diastolic blood 
pressure, respectively.  Interventions consisting of small groups saw significant 
beneficial effects for all six outcomes (dwc= -1.15, 95%CI: -1.61, -0.68; dHDL=0.64, 




0.56; dSBP= -1.42, 95%CI: -1.91, -0.94; dDBP=-1.54, 95%CI: -2.43, -0.65 for waist 
circumference, HDL cholesterol, triglycerides, fasting blood glucose, systolic 
blood pressure, and diastolic blood pressure, respectively) compared to the 
significant effects for two outcomes for those interventions that were primarily 
one-on-one (dwc=-0.54, 95%CI:-0.88, -0.20; dSBP=-0.46, 95%CI:-0.83,-0.09 for 
waist circumference and systolic blood pressure respectively).   
Multiple variables were significant moderators only for diastolic blood 
pressure ( =67.72%, p<0.0001, ;  =72.57%, p<0.0001;  =71.86%, 
p<0.0001 for number of females, total sample size, and sample size of the 
intervention group) resulting in significant associations (BDBP=-0.004, p<0.0001; 
BDBP=-0.004, p<0.0001; BDBP=-0.005, p<0.0001, for number of females, total 
sample size, and sample size of the intervention group, respectively).   
In regards to specific components of the traditional MedSD interventions, 
the following characteristics were not significant moderators for any of the 
metabolic risk factors: carbohydrate intake ≥50% of calories, saturated fat intake 
<10% of calories, total fat intake <30% of calories, and protein intake ≥15% of 
calories.   However, following these specific macronutrient proportions resulted in 
more beneficial effects in favor of the traditional MedSD compared to 
carbohydrate intake <50% of calories, saturated fat intake ≥10% of calories, total 
fat intake ≥30% of calories, and protein intake <15% of calories.  In addition to 
the specific macronutrient proportions of the dietary intervention, whether or not 




dietary counseling were also analyzed as moderators.  There was no significant 
association for either of these variables.  There was a significant trend in favor of 
the MedSD intervention in those interventions that assessed dietary compliance 
as well as those that included dietary counseling as part of the intervention.    
Participant characteristics, in particular the presence or absence of 
certain disease states, were also analyzed as moderators.  These variables 
included the presence or absence of cardiovascular disease, type II diabetes 
mellitus, metabolic syndrome, and overweight/obesity.  None of these variables 
were significant moderators, however certain trends should be noted.  
Participants with metabolic syndrome that followed the traditional MedSD had 
more significant beneficial effects on five out of six of the metabolic risk factors 
than those participants without metabolic syndrome.  Conversely, in this model,  
effects were more beneficial in favor of the MedSD in participants without 
cardiovascular disease and without type II diabetes mellitus than those 
participants with these diseases for all outcomes except HDL cholesterol.  
Overweight/obese participants saw greater effects for waist circumference, 
however, those without overweight/obesity saw greater effects for triglycerides.  
All of the aforementioned effects were favorable, however no significant 
moderation was found for these variables.  Results from the moderator analysis 
can be found in Table 4.  Lists of non-significant moderators and moderators that 
did not have enough information reported to be analyzed can be found in Table 5 




Risk of Bias  
 Risk of bias was unclear for random sequence generation, allocation, 
blinding, incomplete outcome data, selective reporting, and other potential 
sources of bias.  Moderator analysis was not significant for any of the risk of bias 
parameters.   Low risk of bias was found in 28.1% of articles for random 
sequence generation and 9.3% of the articles had low risk of bias for allocation 
concealment.  9.3% of the articles had low risk of bias and 6.3% of the articles 
had high risk of bias for blinding of participants and personnel.  Blinding of 
outcome assessment had 9.3% low risk of bias and 9.3% high risk of bias.  
Imcomplete outcome data in the short-term and long-term both resulted in 6.3% 
of articles with high risk of bias.  No high or low risk of bias was reported for 
selective reporting.  15.6% of articles had low risk of bias for other bias whereas 
3.1% had high risk of bias for other bias.  Refer to Figure 14 for a Risk of Bias 
Summary.   
Discussion 
The present meta-analysis of 32 intervention trials found that the 
traditional MedSD has significant beneficial effects on five out of six of the 
metabolic risk factors: waist circumference, triglycerides, fasting blood glucose, 
systolic blood pressure and diastolic blood pressure.  The significant 
heterogeneity between studies was partly attributed to the location of the studies, 
the length of the intervention, and the IPP value of the journal where the study 




effects of the Mediterranean diet on metabolic syndrome, that meets 100% of the 
AMSTAR criteria.   
Our findings that a traditional MedSD is beneficial in reducing the risk of 
CVD-associated metabolic parameters complements and extends previous work 
in this area.  Several recent systematic reviews and meta-analyses published on 
the MedSD and CVD risk have reported similar positive effects on waist 
circumference, triglycerides, systolic blood pressure, diastolic blood pressure, 
and fasting blood glucose.  These studies also found similar significant positive 
associations in moderator analysis for studies conducted in Mediterranean 
countries8,42, duration of study8, study design42, and study quality8,43.  However, 
we found that in general the meta-analyses and systematic reviews included in 
this analysis possessed limitations in methodological quality, impacting the ability 
to draw conclusions from their findings.   
In our recent review of methologcial quality we used an established 
methodological quality scale, AMSTAR, to evaluate the quality of 20 meta-
analyses and systematic reviews on the MedSD and CVD risk.  This review also 
assessed the relationship between review quality and IPP value of the journal 
where the article had been published.  The PRISMA12 guidelines were used to 
extract scientific literature from eight computer datatbases using a 
comprehensive Boolean search strategy.  Databases were searched until 
November 7, 2013 and 20 reports were coded and included in analysis.  Included 
reports were published between 2006 and 2013.  Five of the reports were meta-




and meta-analyses10.  Four of the included studies reviewed moderation patterns 
and found that the MedSD effect was positive for different CVD risk outcomes 
when, in general: 1) the effect was based on larger samples, 2) the samples 
were more physically active, 3) the study was conducted in a Mediterranean 
country, 4) the study period was longer in duration, and 5) study quality was 
rated higher10.   
We found that reviews published in higher IPP journals scored 
significantly higher in total methodological quality10.  Those reviews with higher 
quliaty scores tended to report moderator analysis and homogeneity inference 
test and did not have language restrictions in their search.  There were three 
positively significant associations between the IPP value and AMSTARMedSD 
aspects: 1) use of duplicate study selection and data extraction, 2) using 
appropriate statistics to combine findings, and 3) using and justifying an 
appropriate effect size index 10.  Given these results, we felt it was imperative to 
follow all current methodological quality standards while conducting our current 
meta-analysis on the traditional MedSD and metabolic risk factors.  As noted 
above, for this current meta-analysis, we were successful in meeting 100% of the 
AMSTAR criteria and in using moderator analysis to explain some of the 
variability between studies. 
 To our knowledge, there has only been one previously published meta-
analysis on the effects of the Mediterranean diet on metabolic syndrome.  This 




studies, and 13 cross-sectional studies with a total of 534,906 participants.  They 
found that overall,  adherence to the Mediterranean diet was aossociated with a 
beneficial effect in regard to waist circumference, HDL cholesterol, triglycerides, 
and fasting glucose levels; overall, adherence to a Mediterranean diet was not 
associated with beneficial effect in regard to systolic and diastolic blood pressure 
levels8.  However, in the present meta-analysis, significant beneficial effects were 
found for waist circumference, triglycerides, fasting blood glucose, systolic blood 
pressure and diastolic blood pressure, but not HDL cholesterol.   
Using sensitivity analysis, Kastorini, et al.8 found significant associations 
for studies conducted in a Mediterranean country and those studies lasting 
longer than three months in duration for the following outcomes: HDL cholesterol, 
triglyercides, systolic blood pressure, diastolic blood pressure, glucose, and 
HOMA-IR8.  Significant asscoications were found for all of the above outcomes 
as well as waist circumference for interventions with more than or equal to 66 
participants8.  Recommendation of physical activity was significantly associated 
with HDL cholesterol, triglycerides, systolic blood pressure, diastolic blood 
pressure, and HOMA-IR, whereas no recommendation of physical activity was 
significantly associated with systolic blood pressure, diastolic blood pressure, 
and glucose8.  Lastly, studies of high quality were significantly associated with 
greater effects on HDL cholesterol, triglycerides, systolic blood pressure, diastolic 
blood pressure, and HOMA-IR8.  In the present meta-analysis, significant 




longer duration, studies using a behavioral technique, studies with a comparison 
intervention group, studies with a higher IPP value, and studies conducted 
primarily in groups for most of the metabolic risk factors.  Our current sample of 
studies did not report enough baseline physical activity information to analyze 
that variable as a moderator.  Interventions that included exercise were excluded 
from this meta-analysis as that was considered a “MedSD plus” intervention 
because it was not looking solely at the effects of the dietary intervention.  For 
the Kastorini, et al.8 meta-analysis, the literature search was limited to those 
manuscripts published in English and to three computer databases.  Small 
literature searches of only a few key terms at a time were conducted rather than 
one comprehensive literature search.  Clinical trials with lack of randomization, 
lack of a control diet group, comparison of the Mediterranean diet against the 
Mediterranean diet plus an additional intervention, or intervention without 
inclusion of all of the components of a Mediterranean diet were excluded from 
analysis 8.  For the present meta-analysis language was not restricted for the 
literature search, a comprehensive literature search was performed using six 
electronic databases, and studies without comparison groups or with a lack of 
randomization were not excluded.  The present meta-analysis and the meta-
analysis by Kastorini, et al.8 greatly contribute to the scientific literature in support 
of the traditional MedSD and can assist with the creation and implementation of 
evidence-based dietary guidelines for those samples that would most benefit 




The Scientific Report of the 2015 Dietary Guidelines Advisory Council 
analyzed the scientific evidence of three healthy dietary patterns, one of which is 
the MedSD9.  This report summarizes the information from large, high-quality 
randomized control trials  related to the effects of the MedSD on multiple health 
outcomes such as blood pressure and blood lipids9.  The Dietary Guidelines 
Advisory council found that there were common characteristics among dietary 
patterns associated with positive health outcomes.  Some of these characteristics 
were similar to those of the traditional MedSD such as higher intake of 
vegetables, fruits, seafood, legumes, and nuts; moderate intake of alcohol 
(among adults); lower consumption of red and processed meat, and low intake of 
sugar-sweetened foods and drinks9.  This reports highlights the significance and 
importance of current, high-quality research on the MedSD.   
Practical Applications 
 The results of this meta-analysis provide researchers and health 
professionals with several immediate applications.  The moderator analysis 
conducted in this meta-analysis demonstrates the importance of intervention 
trials reporting as much detailed information about participant and intervention 
characteristics as possible.  Having this information would make more moderator 
analysis possible allowing for more specific dietary recommendations to be 
created for any dietary pattern, but especially the traditional MedSD.  This meta-
analysis is influential in the fields of dietetics and nutrition as both assessment of 




with positive trends in favor of the MedSD.  The significant association in 
beneficial effects agrees with weight loss interventions conducted by Gokee-
LaRose, et al44. Registered dietitians should be a vital component of any dietary 
intervention trial in order to enhance beneficial effects on the outcomes of 
interest.  More significantly beneficial effects were found in those studies that 
primarily use a small group intervention compared to one-on-one interventions, 
which supports previous findings in dietary intervention studies that use small 
group interventions45.  Most importantly, the results of this meta-analysis agree 
with most of the current systematic reviews and meta-analyses on the 
Mediterranean diet.   
Study Limitation and Strengths 
This meta-analysis has several limitations and stregnths.  There is still 
significant heterogeneity between the studies that is unexplained which is a 
limitation for this study.  Multiple variables did not have enough data reported to 
test for moderation effects.  The data reported in our sample of studies did not 
allow us to control for different types and duration of exercise in which 
participants may have been engaging.  Our last limitation is possible ecological 
fallacy, as we did not have the raw data from the included studies, we should be 
cautious interpreting the group results as individual effects.  There are multiple 
strengths for this meta-analysis.  We used a comprehensive literature search in 
six electronic databases and an inclusive and comprehensive coding form and 




analysis on all variables that reported enough data to do so.  To our knowledge, 
this is the first meta-analysis to find significant associations with the use of 
behavioral techniques and small group interventions.  Lastly, we were able to use 
the moving constant technique and a predictive model to calculate the effect size 
at significant values of each significant moderator and transform that effect size 
into the clinical unit of measure.    
Conclusion 
The results of the present meta-analysis suggest that adherence to the 
traditional MedSD can have significant beneficial effects on wasit circumference, 
triglycerides, fasting blood glucose, systolic blood pressure and diastolic blood 
pressure with a positive trend for HDL cholesterol.  In addition, the 
Mediterranean-style diet was significantly beneficial for different metabolic risk 
factors when, in general the intervention period was longer in duration, the study 
was conducted in Europe, the study was published in a journal with higher 
Impact per Publication value, the study included a comparison intervention, the 
study used a behavioral technique, and the study was conducted primarily using 
small groups.  More high-quality intervention studies are needed to evaluate the 
relationship between the traditional MedSD and metabolic risk factors in order to 
provide more detailed information for moderator analysis.  This high quality meta-
analysis on the effect of the traditional MedSD on metabolic risk factors 
significantly contributes to the current body of scientific literature in favor of 
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Figure 1. PRISMA Figure Outlining the Process of Study Identification, 






Table 1. Description of Included Studies 


























Canada 67 NR 39 Ob (57%) NR Individual, 
supervised 
MD 8 Non-Ob CVDRF 
Bekkouche, 
et al. (2014) 
48
 
Algeria 86 NR 52 MS (67%) Hospital Individual, 
unsupervised 




Bos, et al. 
(2010)49 
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MD 16 None CVDRF 
Corbalan, et 
al. (2009) 52 
Spain 140
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HMD 34 None WT 
Esposito, et 
al. (2006)53 













































HMD 208 LF Diet Glycemic 
control 










MD 12 None Serum 
lipid, WT 










MD 24 None WT 
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MD 52 None MS RF 
Lerman, et 
al. (2010) 63 
United 
States 














al. (2007) 64 





























HMD 12 HMD WT 
Papandreou, 
et al. (2012 
67
 












































al. (2011) 71 
United 
States 






MD 12 None WT, BP, 
TG, serum 
glucose 
Ryan, et al. 
(2013)72 




MD 6 LF diet WT, IS 
Sanchez-
Benito, et al. 











Note. N, number of participants at baseline; F, females; NR, not reported; OWT, Overweight; Ob, Obesity; MD, Mediterranean 
Diet; PDM, Pre-diabetes mellitus; PHTN, Pre-hypertension; HMD, Hypocaloric Mediterranean diet; CVDRF, Cardiovascular 
Disease risk factors; MS, Metabolic Syndrome; Endo dys, endothelial dysfuction;, OS, oxidative stress; NIDDM, Non-insulin 
Dependent Diabetes; FFMD, Fast food Mediterranean Diet; FF Cons, Fast food consumption; IR, insulin resistance; Inflam, 
Inflammation; SFA, saturated fatty acid; IS, Insulin Sensitivity; CHD, Coronary Heart Disease; ED, Erectile Dysfunction; IIEF, 
International Index of Erectile Function; FSD, Female Sexual Dysfunction; FSFI, Female Sexual Function Index; Endo Func., 
endothelial function; Vas Infl, vascular inflammation; MDN, Mediterranean Diet with nuts; MDO, Mediterranean Diet with olive oil; 
EPC, endothelial progenitor cell; OC, serum osteocalcin; P1NP, procollagen type 1 N-terminal propeptide; LGMD-MF, Low-
Glycemic Mediterranean Diet with Medical Food; MS RF, Metabolic Syndrome Risk Factors; AO, antioxidant; HRQoL, Health-
related quality of life; WC, waist circumference; IHD, ischaemic heart disease; IGT, impaired glucose tolerance; KEMEPHY, 
Ketogenic Mediterranean Diet with phytoextracts; OSAS, Obstructive Sleep Apnea Syndrome; TBARS, thiobarbituric acid reacting 
substances; TAC, total antioxidant capacity; HMDC, Hypocaloric Mediterranean Diet High Cereal; HMDV, Hypocaloric 
Mediterranean Diet High Vegetable; BP, blood pressure; TG, serum triglycerides;  Inflam Bio, inflammatory biomarkers; 
MyPyramid for P&B, USDA MyPyramid Diet for Pregnant and Breastfeeding Women; BLS, Bright Liver Score; FVII, activated 
factor VII; HLF Diet, Hypocaloric Low Fat Diet; MI, Myocardial Infarction 
Note on Dietary Assessment column:  
(2012)73 
Stendall-
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• Individual: A dietitian performed a dietary assessment, providing individualized needs for caloric intake and 
recommendations, for each participant. 
• Group: The study provided general dietary recommendations for the participants, such as a range of servings of certain 
food groups, calories based on gender, as opposed to tailoring diets to individual needs based on weight and height. 
• Supervised: Participants consumed foods in a supervised setting, where the researchers had control over participant food 
choices and quantity of food served. 
















Note: WC, waist circumference; HDL, HDL cholesterol; TG, triglycerides, FBG, 
































Table 3. Summary of Results, Overall Effect Sizes and Homogeneity 
Note: WC, waist circumference; HDL, HDL cholesterol; TG, triglycerides, FBG, 
fasting blood glucose; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; * indicates a significant effect; k represents the number of interventions 
for each outcome included in the anlaysis; Q represents Cochran’s Q indicating 
significance of heterogeneity; I2 represents the magnitude of heterogeneity; p-
value represents the significance of heterogeneity.  
Outcome k 
d+ (95% CI) Homogeneity of d’s 
Fixed-Effects Random-Effects 
 
Q I2 (%) p-value 
WC  45 
-0.41 
(-0.45 to -0.38)* 
-0.54 
(-0.75 to -0.33)* 425.29 96.37 <0.0001 
HDL 40 
0.15 
(0.09 to 0.19)* 
0.15 
(-0.02 to 0.32) 304.48 91.1 <0.0001 
TG 38 
-0.27 
(-0.31 to -0.22)* 
-0.34 
(-0.51 to -0.16)* 251.41 91.49 <0.0001 
FBG 33 
-0.36 
(-0.41 to -0.32)* 
-0.42 
(-0.64 to -0.19)* 292.85 94.67 <0.0001 
SBP 30 
-0.61 
(-0.65 to -0.57)* 
-0.62 
(-0.89 to -0.35)* 600.44 97.07 <0.0001 
DBP 30 
-0.68 
(-0.73 to -0.63)* 
-0.78 




Table 4. Significant Moderator Analysis Results 
Significant Moderator Analysis Results 
 
Variable Outcome  Category k d+ (95% CI) R2 p-value 
Clinical Unit of 
Measure 
Study Characteristics  
 
Region WC Europe 23 
-0.82  
(-1.12 to -0.51) 2.90% 0.23 -8.32 cm 
US 7 
-0.33 
 (-0.59 to 0.39) 2.90% 0.23 -3.41 cm 
HDL Europe 13 
0.551  
(0.21 to 0.89) 16.69% 0.08 1.65 mmol/L 
US 6 
-0.01 
 (-0.59 to 0.39) 16.69% 0.08 -0.31 mmol/L 
TG Europe 12 
-0.71 
 (-1.08 to -0.35) 4.42% 0.28 -24.89 mmol/L 
US 4 
-0.13  
(-0.75 to 0.48) 4.42% 0.28 -4.69 mmol/L 
FBG Europe 12 
-0.75 
 (-1.15 to -0.35) 3.50% 0.33 -0.23 mmol/L 
US 3 
-0.181  
(-0.96 to 0.60) 3.50% 0.33 -0.06 mmol/L 
SBP Europe 13 
-0.97 
 (-1.54 to 0.53) 0.00% 0.68 -3.17 mmol/L 
US 4 
-0.47 
 (-1.38 to 0.43) 0.00% 0.68 -1.54 mmol/L 
DBP Europe 13 
-1.27 
 (-2.56 to 0.90) 0.00% 0.79 -2.97 mmol/L 
US 4 
-0.44  




Study Design WC 
MedSD vs. Other 
Diet 13 
-1.14 




 (-0.58 to -0.09) 25.19% 0.001 -3.47 cm 
HDL 
MedSD vs. Other 
Diet 9 
0.79 




 (-0.35 to 0.102) 49.12% <0.0001 -0.36 mmol/L 
TG 
MedSD vs. Other 
Diet 8 
-0.99 




 (-0.45 to 0.05) 33.71% 0.0008 -7.11 mmol/L 
FBG 
MedSD vs. Other 
Diet 7 
-1.13  




(-0.55 to 0.03) 32.81% 0.002 -0.08 mmol/L 
SBP 
MedSD vs. Other 
Diet 7 
-1.36  




 (-0.79 to -0.23) 29.09% 0.003 -1.67 mmHg 
DBP 
MedSD vs. Other 
Diet 7 
-1.32  




 (-1.34 to -0.19) 0.00% 0.34 -1.8 mmHg 
Impact per Publication Metric WC 0 (minimum) 39 
-0.18 
 (-0.42 to 0.06) 45.10% <0.0001 -1.84 cm 
16.104 (maximum) 39 
-1.92  
(-2.49 to -1.36) 45.10% <0.0001 -19.58 cm 
HDL 0 (minimum) 27 
-0.08  
(-0.35 to 0.18) 37.03% 0.002 -0.24mmol/L 




(0.44 to 1.49) 
TG 0 (minimum) 25 
-0.19 
 (-0.49 to 0.11) 23.74% 0.013 -6.65 mmol/L 
16.104 (maximum) 25 
-1.09  
(-1.66 to -0.53) 23.74% 0.013 -38.15 mmol/L 
FBG 0 (minimum) 23 
-0.14 
 (-0.46 to 0.18) 39.48% 0.0005 -0.04 mmol/L 
16.104 (maximum) 23 
-1.44 
 (-2.00 to -0.87) 39.48% 0.0005 -0.44 mmol/L 
SBP 0 (minimum) 25 
-0.55 
 (-0.88 to -0.21) 11.11% 0.16 -1.79 mmHg 
16.104 (maximum) 25 
-1.13 
 (-1.77 to -0.48) 11.11% 0.16 -3.69 mmHg 
DBP 0 (minimum) 25 
-0.63 
 (-1.27 to 0.01) 3.89% 0.16 1.47 mmHg 
   16.104 (maximum) 25 
-1.74  
(-2.98 to -0.49) 3.89% 0.16 -4.07 mmHg 
Intervention Characteristics 
 
























































 (-4.14 to -0.63) 6.84% 0.09 -5.58 mmHg 
Number of Females WC 0 (minimum) 38 
-0.54 
 (-0.79 to -0.29) 0.00% 0.98 -5.51 cm 
1,154 (maximum) 38 
-0.52  
(-1.91 to 0.86) 0.00% 0.98 -5.30 cm 
HDL 0 (minimum) 27 
0.28  
(-0.07 to 0.64) 0.00% 0.48 0.84 mmol/L 
1,154 (maximum) 27 
-2.61 
 (-10.47 to 5.25) 0.00% 0.48 -1.20 mmol/L 
TG 0 (minimum) 25 
-0.40 
 (-0.77 to -0.03) 0.00% 0.74 -14.0 mmol/L 
1,154 (maximum) 25 
-2.03  
(-11.42 to 7.35) 0.00% 0.74 -71.05 mmol/L 
FBG 0 (minimum) 23 
-0.53  
(-0.86 to -0.21) 0.00% 0.96 -0.16 mmol/L 
1,154 (maximum) 23 
-0.49 
 (-1.9 to 0.92) 0.00% 0.96 -0.15 mmol/L 
SBP 0 (minimum) 25 
-0.69 
 (-0.99 to -0.39) 0.00% 0.73 -2.26 mmHg 




 (-2.29 to 0.41) 
DBP 0 (minimum) 25 
-0.55  
(-0.86 to -0.23) 67.72% <0.0001 -1.29 mmHg 
1,154 (maximum) 25 
-5.83 
 (-7.26 to -4.41) 67.72% <0.0001 -13.64 mmHg 
Total sample size WC 12 (minimum) 41 
-0.59  
(-0.87 to -0.32) 0.00% 0.91 -6.02 cm 
1,406 (maximum) 41 
-0.51  
(-1.86 to 0.84) 0.00% 0.91 -5.20 cm 
HDL 12 (minimum) 28 
-0.15  
(-0.55 to 0.25) 12.82% 0.05 -0.45 mmol/L 
1,406 (maximum) 28 
5.29  
(0.07 to 10.51) 12.82% 0.05 15.87 mmol/L 
TG 12 (minimum) 26 
-0.17 
 (-0.58 to 0.23) 7.69% 0.11 -5.95 mmol/L 
1,406 (maximum) 26 
-5.22  
(-11.02 to 0.59) 7.69% 0.11 -182.7 mmol/L 
FBG 12 (minimum) 24 
-0.49 
 (-0.82 to -0.17) 0.00% 0.79 -0.15 mmol/L 
1,406 (maximum) 24 
-0.69  
(-2.07 to -0.68)  0.00% 0.79 -0.21 mmol/L 
SBP 12 (minimum) 26 
-0.72  
(-1.05 to -0.39) 0.00% 0.72 -2.35 mmHg 
1,406 (maximum) 26 
-0.99 
 (-2.37 to 0.39) 0.00% 0.72 -3.24 mmHg 
DBP 12 (minimum) 26 
-0.39 
 (-0.69 to -0.94) 72.57% <0.0001 -0.91 mmHg 
1,406 (maximum) 26 
-5.94 
 (-7.22 to -4.66) 72.57% <0.0001 -13.89 mmHg 
Sample size of intervention group WC 11 (minimum) 41 
-0.59  




1,154 (maximum) 41 
-0.51 
 (-1.91 to 0.89) 0.00% 0.91 -5.20 cm 
HDL 11 (minimum) 28 
0.09  
(-0.29 to 0.46) 0.00% 0.55 0.27 mmol/L 
1,154 (maximum) 28 
2.3  
(-4.69 to 9.31) 0.00% 0.55 6.9 mmol/L 
TG 11 (minimum) 26 
-0.31  
(-0.68 to 0.06) 0.00% 0.34 -10.85 mmol/L 
1,154 (maximum) 26 
-4.18  
(-11.8 to 3.45) 0.00% 0.34 -146.3 mmol/L 
FBG 11 (minimum) 24 
-0.51 
 (-0.83 to -0.19) 0.00% 0.93 -0.16 mmol/L 
1,154 (maximum) 24 
-0.57  
(-1.95 to 0.81) 0.00% 0.93 -0.18 mmol/L 
SBP 11 (minimum) 26 
-0.73 
 (-1.04 to -0.41) 0.00% 0.74 -2.39 mmHg 
1,154 (maximum) 26 
-0.97  
(-2.36 to 0.42) 0.00% 0.74 -3.17 mmHg 
DBP 11 (minimum) 26 
-0.49  
(-0.78 to -0.20) 71.86% <0.0001 -1.15 mmHg 
1,154 (maximum) 26 
-5.94  




(-1.05 to 0.41) 0.85% 0.21 -1.05 mmHg 
Use of a behavioral technique WC No 24 
-0.41 
 (-0.71 to -0.11) 2.26% 0.17 -4.18 cm 
Yes 16 
-0.73 
 (-1.08 to -0.38) 2.26% 0.17 -7.45 cm 
HDL No 16 
-0.08  
(-0.42 to 0.25) 14.18% 0.03 -0.24 mmol/L 




 (0.12 to 0.89) 
TG No 16 
-0.27 
 (-0.59 to 0.60) 9.97% 0.05 -9.45 mmol/L 
Yes 9 
-0.79  
(-1.21 to -0.37) 9.97% 0.05 -27.65 mmol/L 
FBG No 13 
-0.31 
 (-0.69 to 0.07) 11.94% 0.06 -0.09 mmol/L 
Yes 9 
-0.88  
(-1.34 to -0.43) 11.94% 0.06 -0.27 mmol/L 
SBP No 15 
-0.54  
(-0.92 to -0.17) 11.98% 0.05 -1.77 mmHg 
Yes 10 
-1.12  
(-1.56 to -0.68) 11.98% 0.05 -3.66 mmHg 
DBP No 15 
-0.53 
 (-1.16 to 0.11) 13.48% 0.03 -1.24 mmHg 
Yes 10 
-1.63  
(-2.35 to -0.85) 13.48% 0.03 -3.81 mmHg 





(-0.88 to -0.20) 16.12% 0.01 -5.51 cm 
Small groups 9 
-1.15  





 (-0.49 to 0.27) 22.31% 0.01 -0.33 mmol/L 
Small groups 9 
0.64 





 (-0.50 to 0.20) 25.64% 0.006 -5.25 mmol/L 
Small groups 7 
-1.03  









Small groups 7 
-1.04  





(-0.83 to -0.09) 30.73% 0.005 -1.50 mmHg 
Small groups 7 
-1.42 





(-1.02 to 0.34) 13.86% 0.05 -0.79 mmHg 
Small groups 7 
-1.54 
 (-2.43 to -0.65) 13.86% 0.05 -3.60 mmHg 
Note: WC, waist circumference; HDL, HDL cholesterol; TG, triglycerides, FBG, fasting blood glucose; SBP, systolic 
blood pressure; DBP, diastolic blood pressure; k is the number of interventions included in the analysis for each 
outcome; R2 indicates the percentage of heterogeneity that the moderator accounts for; Clinical Unit of Measure was 





Table 5. Non-Significant Moderators 
Non-Significant Moderators 
Proportion of females 
Proportion of participants with any type of disease 
Number of participants with any type of disease 
Proportion of partcipants taking any type of 
medication 
Number of participants taking any type of medication 
Type of medication use 
Experimental setting 
Number of participants who dropped out of the 
intervention 
Length of counseling sessions 
Number of counseling sessions 
Specific type of diet 
Publication Year 
Language of publication 
Recruitment type/Specific population 
Proportion of carbohydrate intake (<50% or ≥50%) 
Proportion of saturated fat intake (<10% or ≥10%) 
Proportion of total fat intake (<30% or ≥30%) 
Mean Age of the Sample 
Proportion of protein intake (<15% or ≥15%) 
Assessment of dietary compliance 
Participation in dietary counseling 
Population with cardiovascular disease 
Population with Type II Diabetes Mellitus 
Population with Metabolic Syndrome 







Table 6. Moderators that were Unable to be analyzed due to lack of 
Reported Information 
Moderators Unable to be Analyzed 
Oral contraceptive/hormone-replacement 
therapy 
Proportion of participants who smoke 
Number of participants that smoke 
Supplement use 
Alcohol intake 
Number of alcoholic drinks/week 
Type of alcohol consumption 
Amount of exercise/week 
Type of exercise 
Was dietary adherence monitored 
Were medications part of the intervention 
Total calories consumed on the intervention 
diet 
Dietary sodium intake 
Dietary potassium intake 
Unsaturated fat intake 
Saturated fat intake 
Cholesterol intake 
Fiber intake 
Servings of vegetables recommended 
Servings of dairy recommended 
Servings of wine recommended 
Servings of fish recommended  
Servings of olive oil recommended 
Servings of legumes recommended  
Servings of meat recommended 







Figure 2. Forest Plot for Waist Circumference
 
Note: Squares represent point estimates for each individual study; extended line 
shows 95% confidence intervals (Cis); dotted line represents the null value of 




Figure 3. Forest Plot for HDL
 
Note: Squares represent point estimates for each individual study; extended line 
shows 95% confidence intervals (Cis); dotted line represents the null value of 




Figure 4. Forest Plot for Triglycerides
 
Note: Squares represent point estimates for each individual study; extended line 
shows 95% confidence intervals (Cis); dotted line represents the null value of 




Figure 5. Forest Plot for Fasting Blood Glucose 
 
Note: Squares represent point estimates for each individual study; extended line 
shows 95% confidence intervals (Cis); dotted line represents the null value of 




Figure 6. Forest Plot for Systolic Blood Pressure 
 
Note: Squares represent point estimates for each individual study; extended line 
shows 95% confidence intervals (Cis); dotted line represents the null value of 




Figure 7. Forest Plot for Diastolic Blood Pressure 
 
Note: Squares represent point estimates for each individual study; extended line 
shows 95% confidence intervals (Cis); dotted line represents the null value of 


















Note: Number of weeks of the intervention is represented on the x-axis; Outcome 
of interest is represented on the y-axis; B is the unstandardized beta and 
represents the amount of change in the outcome per week of the intervention; R2 

























Note: Number of weeks of the intervention is represented on the x-axis; Outcome 
of interest is represented on the y-axis; B is the unstandardized beta and 
represents the amount of change in the outcome per week of the intervention; R2 
indicates the percentage of variability accounted for by length.   







Note: Number of weeks of the intervention is represented on the x-axis; Outcome 
of interest is represented on the y-axis; B is the unstandardized beta and 
represents the amount of change in the outcome per week of the intervention; R2 





















Note: Number of weeks of the intervention is represented on the x-axis; Outcome 
of interest is represented on the y-axis; B is the unstandardized beta and 
represents the amount of change in the outcome per week of the intervention; R2 
indicates the percentage of variability accounted for by length.   







Note: Number of weeks of the intervention is represented on the x-axis; Outcome 
of interest is represented on the y-axis; B is the unstandardized beta and 
represents the amount of change in the outcome per week of the intervention; R2 













Figure 13. Meta-Regression Plot for Diastolic Blood Pressure
Note: Number of weeks of the intervention is represented on the x
of interest is represented on the y
represents the amount of change in the outcome per week of the intervention; R


















Appendix 1. Comprehensive Literature Search Strategy 
All databases searched until August 4, 2014. 
1. PubMed, years 1940s-present 
Terms were searched in all fields; however, field labels were used to 
restrict specific terms/phrases to the Medical Subject Headings [Mesh], 
publication type [pt] and journal name [ta] fields. 
 (“Mediterranean diet” OR "Mediterranean diets" OR “Mediterranean dietary” OR 
"Mediterranean style diet" OR "Mediterranean style diets" OR "Diet, 
Mediterranean"[Mesh])  AND (adiposity OR "metabolic syndrome" OR overweight 
OR BMI OR "body mass" OR "waist circumference" OR weight [tiab] OR “body 
weight” OR obese OR obesity OR "abdominal fat" OR "Weight Loss"[Mesh] OR 
“weight loss” OR  "Diet, Reducing"[Mesh]) NOT ("Cross-Sectional Studies"[MeSH 
Terms] OR "Case Reports"[pt] OR Comment[pt] OR Editorial[pt] OR Letter[pt] OR 
Review[pt] OR "case control"[ti] OR "case report"[ti] OR "case study"[ti] OR "case 
series"[ti] OR "Case-Control Studies"[Mesh] OR "Follow-Up Studies"[Mesh] OR 
"observational study"[ti] OR "prospective cohort"[ti] OR "cohort 
studies"[Mesh:noexp] OR "cohort study"[ti] OR "Longitudinal 
Studies"[Mesh:noexp] OR "Follow-Up Studies"[mesh] OR "Retrospective 
Studies"[mesh] OR "non-randomized"[ti] OR "follow up study"[ti] OR rat[ti] OR 
rats[ti] OR mice[ti] OR mouse[ti] OR dog[ti] OR dogs[ti] OR cats[ti]) 
Results: 431 
2. EMBASE (via Scopus) years 1823-present 
All terms were searched in “Article Title, Abstract, Keywords”. Because of 
character restrictions in Scopus, this search was run in parts and 
assembled using the “Search history”. 
Limit to Document type: “Article” 
{Mediterranean diet} OR {Mediterranean diets} OR {Mediterranean dietary} OR 
{Mediterranean style diet} OR {Mediterranean style diets}  
AND (adiposity OR {weight loss} OR {metabolic syndrome} OR overweight OR 
BMI OR {body mass} OR {waist circumference} OR weight OR {body weight} OR 
obese OR obesity OR {abdominal fat}) 
NOT (in article title) ({Cross-Sectional Studies} OR {Case Reports} OR Comment 
OR Editorial OR Letter OR Review OR {case control} OR {case report} OR {case 
study} OR {case series} OR {Follow-Up Study} OR {observational study} OR 




Studies} OR {Retrospective Studies} OR {non-randomized} OR {follow up study} 
OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats) 
Results: 515 
3. Web of Science, years 1974-present 
All terms were searched in “Topic”.  
Limit to Document type: “article” 
"Mediterranean diet" OR "Mediterranean diets" OR "Mediterranean dietary" OR 
"Mediterranean style diet" OR "Mediterranean style diets" 
AND 
(adiposity OR "weight loss" OR "metabolic syndrome" OR overweight OR BMI 
OR "body mass" OR "waist circumference" OR weight OR "body weight" OR 
obese OR obesity OR "abdominal fat") 
NOT (in title) ("Cross-Sectional Studies" OR "Case Reports" OR Comment OR 
Editorial OR Letter OR Review OR "case control" OR "case report" OR "case 
study" OR "case series" OR "Follow-Up Study" OR "observational study" OR 
"prospective cohort" OR "cohort study" OR "Longitudinal Study" OR "Follow-Up 
Studies" OR "Retrospective Studies" OR "non-randomized" OR "follow up study" 
OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats) 
Results: 890 
4. CINAHL 
All terms were searched in all fields. 
Excluded: MEDLINE Records 
Limited to: research articles 
"Mediterranean diet" OR "Mediterranean diets" OR "Mediterranean dietary" OR 
"Mediterranean style diet" OR "Mediterranean style diets" 
AND 
(adiposity OR "weight loss" OR "metabolic syndrome" OR overweight OR BMI 
OR "body mass" OR "waist circumference" OR weight OR "body weight" OR 
obese OR obesity OR "abdominal fat") 
NOT (in title) ("Cross-Sectional Studies" OR "Case Reports" OR Comment OR 
Editorial OR Letter OR Review OR "case control" OR "case report" OR "case 
study" OR "case series" OR "Follow-Up Study" OR "observational study" OR 




Studies" OR "Retrospective Studies" OR "non-randomized" OR "follow up study" 
OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats) 
Results :  25 
5. Agricola years 1970-present 
Searched in “All Fields”  
Limited to “academic journals” 
"Mediterranean diet" OR "Mediterranean diets" OR "Mediterranean dietary" OR 
"Mediterranean style diet" OR "Mediterranean style diets" 
AND 
(adiposity OR "weight loss" OR "metabolic syndrome" OR overweight OR BMI 
OR "body mass" OR "waist circumference" OR weight OR "body weight" OR 
obese OR obesity OR "abdominal fat") 
NOT (in title) ("Cross-Sectional Studies" OR "Case Reports" OR Comment OR 
Editorial OR Letter OR Review OR "case control" OR "case report" OR "case 
study" OR "case series" OR "Follow-Up Study" OR "observational study" OR 
"prospective cohort" OR "cohort study" OR "Longitudinal Study" OR "Follow-Up 
Studies" OR "Retrospective Studies" OR "non-randomized" OR "follow up study" 
OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats) 
Results: 123 
6. CAB Direct years 1973-present 
Limit to Document Type: Journal article  
"Mediterranean diet" OR "Mediterranean diets" OR "Mediterranean dietary" OR 
"Mediterranean style diet" OR "Mediterranean style diets" 
AND 
(adiposity OR "weight loss" OR "metabolic syndrome" OR overweight OR BMI 
OR "body mass" OR "waist circumference" OR weight OR "body weight" OR 
obese OR obesity OR "abdominal fat") 
NOT (in title) ("Cross-Sectional Studies" OR "Case Reports" OR Comment OR 
Editorial OR Letter OR Review OR "case control" OR "case report" OR "case 
study" OR "case series" OR "Follow-Up Study" OR "observational study" OR 
"prospective cohort" OR "cohort study" OR "Longitudinal Study" OR "Follow-Up 
Studies" OR "Retrospective Studies" OR "non-randomized" OR "follow up study" 
OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats) 




Appendix 2. Screening Form 
                                                                                           Study ID: _________ 
                                                                                      Coder: __________ 
Mediterranean Diet Obesity Meta-Analysis Selection Criteria 
Inclusion Criteria 
Trials MUST match all of these criteria: 
 
 
Exclusion Criteria  
Studies CANNOT include any of the 
following: 
 
Pre- AND Post-intervention weight 





Waist Circumference          
    
 
Mediterranean diet (as a whole, for 
example, not just olive oil) for at least 
one of the  interventions. Can also be 
described as Mediterranean-style diet, 
hypocaloric Mediterranean diet, etc. 
 
 


























     
      
     










Appendix 3. Mediterranean Diet Coding Form (finalized July 
2014) 
CODER________    Coder (Marissa=1, Julia=2, Other=3) 
 
Study Information 
ID _______   Study ID (first 3 letters of 1st author’s last name & unique ID#: Pescatello= 
PES001), ___________________ (Last name, Yr)  
PUB_YR  ________   Publication year (consider this missing if unpublished) 
DATA  ________   Estimated year of data collection (earliest date for data collection 
or manuscript submission/publication;  
   if unpublished and date unknown, use year manuscript was acquired; 
for dissertation or thesis, use year)  
 
LANG ________   Language of report 1=English     2=Spanish     3=Japanese     
4=Other, specify: _________________________ 
SOURCE________   Publication Type 1=journal    2=book    3=thesis/dissertation    
4=conference paper    5= unpublished 
     





PUBMED NAME/ ABBR. 
_________________________________________________________________ 
 
FUNDING SOURCE_______   1= Gov’nt (i.e., CDC, NIH, etc)     2= Academic/University     
3= Private     4= Other 






NOTE_STUDY________ study notes (make note of multiple arms; ex. MD vs. low fat 









Sample Characteristics (proportion: 0.0- 1.0) Note: IF ethnicity is reported, ETH_EST 
will be == 0 
 
ETH ________   Ethnicity reported?    1 = yes; 0 = no   
PROP_WH ______ Proportion White; whole #____  
 PROP_BLK ______ Proportion Black/ whole #____  
PROP_ASIAN ______ Proportion Asian/ whole #____  
 PROP_MIX ______ Proportion Mixed (other)/ whole #____ 
PROP_HISP ______ Proportion Latino/Hispanic/ whole #____  
PROP_CARIB ______ Proportion Caribbean/ whole #____  
ETH_EST  ________   Assumed ethnicity (0= n/a, 1= White, 2= Asian, 3= 
Black, 4= Unreported, 5= Hispanic/Latino) 
 
NUM_FemCON  ________   # of Females in Sample; Proportion 
(#  ⁄ :___________ 
NUM_FemIN1  ________   # of Females in Sample; Proportion 
(#  ⁄ :___________ 
NUM_FemIN2  ________   # of Females in Sample; Proportion 
(#  ⁄ :___________ 
NUM_FemIN3 ________   # of Females in Sample; Proportion 
(#  ⁄ :___________ 
 
REGION________   Location of sample (if unreported, use location of first author 
as estimate of study location) 
1=American city: __________________ US_ZIP_______  
 2=other US region (city= unreported):_____________ 
3=Canada (city: _______________________)   
 4=Europe (city: _______________________)  
5=South/Central America, Mexico, Caribbean (city: _______________)
 6=Africa (city: _______________________) 
7=Asia (city: Osaka, Japan)      8=Australia 
(city: _______________________) 
  
POP ________ Population 0=not reported  1=school/college     2=community 




 3= clinical/hospital (e.g., cardiac rehab, outpatient clinic, etc.) 
_______________________________ 
  
NOTE_RECRUIT Notes on recruitment/ sample location 
__________________________________________________ 
 
Risk Characteristics- report values of baseline data (check methods or descriptive 
tables) KEEP DATA SEPARATE FOR GROUPS  
 
TOTAL_POP ________   Reported as total sample? (1=yes, 0=no) *if data is 





























_   
 Mean age 
(years) AGE  AGE  AGE  AGE  








0= Healthy  
3= CVD(s) (i.e., 
CAD, PAD, 
HF, MI) 
4= Stroke 5= 
Diabetes 
6= MetS 
 7= Arthritis 
8= Dyslipidemia  








DISEASE DISEASE DISEASE DISEASE 



















































Medication use  
(0=no, 1= 
yes) 
MED MED MED MED 




use 0=NA (if 












Type (if no 


























































use (1= yes, 
0=no)  
If unreported == 
“.” 
BPMedUse BPMedUse BPMedUse BPMedUse 




















If taking meds, 
is BP 
controlled?  






OR DBP>90  
(*if no BP 
use == NA) 
BPControl BPControl BPControl BPControl 
LIFESTYLE VARIABLES  
Oral 
Contraceptiv















































_   
months) 
(0=no,1=yes
; if missing = 
“.”) 


























SUPP SUPP SUPP SUPP 
If yes, specify 





ALC ALC ALC ALC 




AMT AMT AMT AMT 
If yes, what 
type of 
alcohol? 

















NOTE_RISK Notes on risk characteristics relevant to coding 
_____________________________________________ 
 
Methods & Design 
CON_GRP ________    Type of control group used 
 1= random assignment of individuals to conditions including a non-diet 
control group, specify_________________ 
 2= random assignment of individuals to conditions including non-diet 
control session 
 3= random assignment of individuals to non-MD condition/diet 
 4= random assignment of individuals a non-diet control group 




Experiment/ Intervention Conditions 
 
EXPERIMENT________ INTERVENTIONS/EXPERIMENTAL CONDITION(S)  
 
1= non-diet control/comparison + 1 intervention  2= non-diet 
control/comparison + 2 interventions    
3= non-diet control/comparison + 3 interventions 
 
4= diet control/comparison + 1 intervention  5= diet control/comparison 
+ 2 interventions    
6= diet control/comparison + 3 interventions    
    
 
EXP_SETTING________ Setting of Intervention(s) 1= hospital       2= clinic       
3= academic/research lab       4= fitness center, gym 
5= Other, specify: ___________________________________                6= 
multiple, specify:__________  
  
DIET_MONITOR________   Was diet adherence monitored? (0= none; 1= yes) 




BEHAV_TECH__________Behavioral technique/monitoring system 






Examples: positive reinforcement/contingency management, exercise & lifestyle 
information/lectures; PA logs, etc.  
 
INTER_LVL________ Level of intervention or supervision used in the study 
1=primarily 1-on-1      2=small group processes (supervisor & group members)    
3= supervised session(s)  
4= unsupervised session(s)     5=incentive (payment based on sessions attended)     
6= multiply, specify #’s:_____________________________  
 






COMPARISON IN1 IN2 IN3 
LENGTH___(in weeks)  LENGTH__ LENGTH__ LENGTH__ LENGTH__ 
WTGain/WTLoss___ 










PART_LOST # of drop outs  
    
ADHERENCE (report %) If 




 x 100) 
    
Were medications used as part 
of the intervention? (0=no, 
1=yes) 
MEDS__ MEDS__ MEDS__ MEDS__ 
If yes, specify 
1= β Blockers 2= Nitrates 
3= Ca+2 Channel Blockers 
4= Angiotension Converting 
Enzyme (ACE) Inhibitors 
5= Diuretics 6= 
Vasodilators  
7= NSAIDs 8= Aspirin 
9= Statins 10=Other, 
specify:  
11= Multiple, specify: ________ 
MED__TYPE  MED__TYPE MED__TYPE MED__TYPE 
DIET__TYPE 
(1=MedDiet, 2=low-fat, 3=high 
protein, 4=low-carb, 
5=other, specify) 
DIET__TYPE  DIET__TYPE DIET__TYPE DIET__TYPE 
Provision of Med Diet Foods? (0=no, 1=yes) 
If yes, type and amount___ 






    
Diet specification reported as a distribution of macronutrients? (0=no, 1=yes) 























KCAL_Rx Prescribed kcals per 
day    
KCAL_REPORT Reported kcals 

















Energy restriction (kcal or %)
     
KCAL_RES (unit= kcal) OR 
RES_PERCENT (%) 
    
SOD_INTAKE (mg/day) 
    
POT_INTAKE (mg/day) 
    
FAT_INTAKE (g/day)    
Unsaturated: FAT_UNSAT 
          Saturated: 
















Dietary Fiber Intake (g/day)    
FIB_INTAKE     
Servings/week: Fruit and/or 
Vegetables    
VEG_SER 
    
Servings/week: Dairy
 DAIRY_SER     
Servings/week: Wine   
WINE_SER     
Servings/week: Whole Grains  
GRAIN_SER     
Servings/week: Fish  
FISH_SER     
Servings/week: Olive Oil   
OIL_SER 
    
Servings/week: Nuts   
NUTS_SER 
    
Servings/week: Legumes   
LEG_SER 
    
Servings/week: Red/processed 
meat   MEAT_SER 
    
Servings/week: Poultry   
POUL_SER 
    
Dietary Compliance & Counseling 
DI_COMPLIANCE   Was Dietary 
compliance assessed? 0= 
No; 1= Yes) 
    
If yes, specify: 
(1=FFQ, 2=Food journal, 
3=phone interviewing, 4=24 
hr recall, 
5=other,specify___)  
    
Was diet adherence measured 
pre, during, or post 
intervention? (1=pre, 
2=during, 3=post, 
4=pre,during, and post, 
5=pre and post, 6=not 
reported) 
    
Is a scale used to measure 
adherence? (0=no, 1=yes)     
If yes, specify type of scale 
used___     
DI_COUNSELING   Participation 
in dietary counseling? 0= no; 
1= yes 
    
If Dietary Counseling was 
provided, report: 
COUNSEL_HR   hours per week 
COUNSEL_SESS sessions per 













DIET_TOPIC  If Dietary 
Counseling was provided, 
 
 


























briefly state topics covered 
QoL Was Quality of Life (QoL) 
assessed? 0=no, 1=yes, if 
yes, report tool or scale 
    




# of follow-ups     




Appendix 4. SAS Code 
Import Data 
To read data set: 
proc print data=midterm; 
run; 
To get mean, range, and standard deviation of certain variables (various dummy 
codes were created in Excel prior to analysis): 
proc means data=midterm n sum mean max min range std; 
class Diet Article; 
run; 
To calculate percentages for language and region of publication: 
proc freq data=midterm; 
run; 
Age of participants was in a separate spreadsheet (weighted mean and std of 
age was calculated by hand): 
proc print data=age; 
run; 

















Appendix 5. R Syntax 
Run the Library 
Library(“metafor”) 
Overall Effect Sizes 





method="REML", slab= paste(Reference, Year, sep="")) 
model2 





method="REML", slab= paste(Reference, Year, sep="")) 
model6 





method="REML", slab= paste(Reference, Year, sep="")) 
model8 







method="REML", slab= paste(Reference, Year, sep="")) 
model10 





method="REML", slab= paste(Reference, Year, sep="")) 
model12 





method="REML", slab= paste(Reference, Year, sep="")) 
model14 
Forest Plots 
#this determines the xleft, xright, ybottom, ytop in the plot in order to use 
this information to determine where to instert text 
#TMD and WC 
par("usr") 
forest(model2, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8, 
efac=2, col="dark red", border="black") 
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the 
plot 
op<-par(cex=0.85, font=2, col="dark red") #to change the size, the font, and the 
color of the inserted text in the plot 
text (0,45, "Waist Circumference") #the first number indicates where the title 
starts and the second number how high in the plot 
text(c(-4,4),44,c("Favors Intervention", "Favors Baseline")) #here the -8 is telling 
us the position where favors intervention starts and 7 where the position where 
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favors baseline starts, and they both are at the 22 height in the plot, if you count 
the number of authors are 20, plus the line where RE Model is that is 21 rows, so 
the labels Author, and Favors are in line 22 
text(-10,44, "Author(s) and Year", pos=4) 
text(7.5,44, "d[95%CI]", pos=4) 
par(op) 
#TMD and HDL 
par("usr") 
forest(model6, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8, 
efac=2, col="dark red", border="black") 
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the 
plot 
op<-par(cex=0.85, font=2, col="dark red") #to change the size, the font, and the 
color of the inserted text in the plot 
text (0,31, "HDL") #the first number indicates where the title starts and the 
second number how high in the plot 
text(c(-3,3),30,c("Favors Baseline ", "Favors Intervention")) #here the -8 is telling 
us the position where favors intervention starts and 7 where the position where 
favors baseline starts, and they both are at the 22 height in the plot, if you count 
the number of authors are 20, plus the line where RE Model is that is 21 rows, so 
the labels Author, and Favors are in line 22 
text(-10,30, "Author(s) and Year", pos=4) 
text(8,30, "d[95%CI]", pos=4) 
par(op) 
#TMD and TG 
par("usr") 
forest(model8, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8, 
efac=2, col="dark red", border="black") 
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the 
plot 
op<-par(cex=0.85, font=2, col="dark red") #to change the size, the font, and the 
color of the inserted text in the plot 
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text (0,29, "Triglycerides") #the first number indicates where the title starts and 
the second number how high in the plot 
text(c(-4,4),28,c("Favors Intervention", "Favors Baseline")) #here the -8 is telling 
us the position where favors intervention starts and 7 where the position where 
favors baseline starts, and they both are at the 22 height in the plot, if you count 
the number of authors are 20, plus the line where RE Model is that is 21 rows, so 
the labels Author, and Favors are in line 22 
text(-10,28, "Author(s) and Year", pos=4) 
text(8,28, "d[95%CI]", pos=4) 
par(op) 
#TMD and FBG 
par("usr") 
forest(model10, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8, 
efac=2, col="dark red", border="black") 
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the 
plot 
op<-par(cex=0.85, font=2, col="dark red") #to change the size, the font, and the 
color of the inserted text in the plot 
text (0,27, "Glucose") #the first number indicates where the title starts and the 
second number how high in the plot 
text(c(-4,4),26,c("Favors Intervention", "Favors Baseline")) #here the -8 is telling 
us the position where favors intervention starts and 7 where the position where 
favors baseline starts, and they both are at the 22 height in the plot, if you count 
the number of authors are 20, plus the line where RE Model is that is 21 rows, so 
the labels Author, and Favors are in line 22 
text(-10,26, "Author(s) and Year", pos=4) 
text(8,26, "d[95%CI]", pos=4) 
par(op) 
#TMD and SBP 
par("usr") 
forest(model12, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8, 
efac=2, col="dark red", border="black") 




op<-par(cex=0.80, font=2, col="dark red") #to change the size, the font, and the 
color of the inserted text in the plot 
text (0,29, "Systolic Blood Pressure") #the first number indicates where the title 
starts and the second number how high in the plot 
text(c(-4,4),28,c("Favors Intervention", "Favors Baseline")) #here the -8 is telling 
us the position where favors intervention starts and 7 where the position where 
favors baseline starts, and they both are at the 22 height in the plot, if you count 
the number of authors are 20, plus the line where RE Model is that is 21 rows, so 
the labels Author, and Favors are in line 22 
text(-10,28, "Author(s) and Year", pos=4) 
text(8,28, "d[95%CI]", pos=4) 
par(op) 
#TMD and DBP 
par("usr") 
forest(model14, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8, 
efac=2, col="dark red", border="black") 
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the 
plot 
op<-par(cex=0.85, font=2, col="dark red") #to change the size, the font, and the 
color of the inserted text in the plot 
text (0,29, "Diastolic Blood Pressure") #the first number indicates where the title 
starts and the second number how high in the plot 
text(c(-4,4),28,c("Favors Intervention", "Favors Baseline")) #here the -8 is telling 
us the position where favors intervention starts and 7 where the position where 
favors baseline starts, and they both are at the 22 height in the plot, if you count 
the number of authors are 20, plus the line where RE Model is that is 21 rows, so 
the labels Author, and Favors are in line 22 
text(-10,28, "Author(s) and Year", pos=4) 
text(8,28, "d[95%CI]", pos=4) 
par(op) 
Publication Bias 










#pub bias for med Diet and HDL 
#Egger's 






#pub bias for med Diet and Triglyceride 
#Egger's 






#pub bias for med Diet and Glucose 
#Egger's 








#pub bias for med Diet and SBP 
#Egger's 






#pub bias for med Diet and DBP 
#Egger's 






Syntax to create subsets 
tmdwc<-subset(Final, Diet==1 & Out==1) 
tmdhdl<-subset(Final, Diet==1 & Out==3) 
tmdtg<-subset(Final, Diet==1 & Out==4) 
tmdfbg<-subset(Final, Diet==1 & Out==5) 
tmdsbp<-subset(Final, Diet==1 & Out==6) 
tmddbp<-subset(Final, Diet==1 & Out==7) 




model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(RanSeq)-1, data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(RanSeq)-1, data=Quality, method="REML") 
summary(model54) 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(RanSeq)-1, data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(RanSeq)-1, data=Quality, method="REML") 
summary(model56) 
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(RanSeq)-1, data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(RanSeq)-1, data=Quality, method="REML") 
summary(model58) 
#RanSeq 
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(RanSeq), data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(RanSeq), data=Quality, method="REML") 
summary(model54) 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(RanSeq), data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(RanSeq), data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(RanSeq), data=Quality, method="REML") 
summary(model58) 
#AllCon-1 
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(AllCon)-1, data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(AllCon)-1, data=Quality, method="REML") 
summary(model54) 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(AllCon)-1, data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(AllCon)-1, data=Quality, method="REML") 
summary(model56) 
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(AllCon)-1, data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(AllCon)-1, data=Quality, method="REML") 
summary(model58) 
# AllCon 
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(AllCon), data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 




model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(AllCon), data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(AllCon), data=Quality, method="REML") 
summary(model56) 
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(AllCon), data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(AllCon), data=Quality, method="REML") 
summary(model58) 
#Blinding-1 
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(Blinding)-1, data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(Blinding)-1, data=Quality, method="REML") 
summary(model54) 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(Blinding)-1, data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(Blinding)-1, data=Quality, method="REML") 
summary(model56) 
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(Blinding)-1, data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 





model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(Blinding), data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(Blinding), data=Quality, method="REML") 
summary(model54) 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(Blinding), data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(Blinding), data=Quality, method="REML") 
summary(model56) 
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(Blinding), data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(Blinding), data=Quality, method="REML") 
summary(model58) 
#Incomp-1 
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(Incomp)-1, data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(Incomp)-1, data=Quality, method="REML") 
summary(model54) 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(Incomp)-1, data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(Incomp)-1, data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(Incomp)-1, data=Quality, method="REML") 
summary(model58) 
#Incomp 
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(Incomp), data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(Incomp), data=Quality, method="REML") 
summary(model54) 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(Incomp), data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(Incomp), data=Quality, method="REML") 
summary(model56) 
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(Incomp), data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(Incomp), data=Quality, method="REML") 
summary(model58) 
#Select 
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(Select), data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 




model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(Select), data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(Select), data=Quality, method="REML") 
summary(model56) 
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(Select), data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(Select), data=Quality, method="REML") 
summary(model58) 
#Select-1 
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(Select)-1, data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(Select)-1, data=Quality, method="REML") 
summary(model54) 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(Select)-1, data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(Select)-1, data=Quality, method="REML") 
summary(model56) 
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(Select)-1, data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 





model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(OtherBias)-1, data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(OtherBias)-1, data=Quality, method="REML") 
summary(model54) 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(OtherBias)-1, data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(OtherBias)-1, data=Quality, method="REML") 
summary(model56) 
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(OtherBias)-1, data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(OtherBias)-1, data=Quality, method="REML") 
summary(model58) 
#OtherBias 
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(OtherBias), data=Quality, method="REML") 
summary(model53) 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(OtherBias), data=Quality, method="REML") 
summary(model54) 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(OtherBias), data=Quality, method="REML") 
summary(model55) 
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(OtherBias), data=Quality, method="REML") 
summary(model57) 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(OtherBias), data=Quality, method="REML") 
summary(model58) 







































Moderation with Weeks and Metaregression Plot 
model21<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=Weeks, 
data=Final, method="REML", slab= paste(Reference, Year, sep =",")) 
model21pred <- predict(model21, newmods=cbind(seq(0,208,.1))) 
wi = Final$w_d.ex. 
min= min(wi,na.rm=TRUE) 
max= max(wi,na.rm=TRUE) 
size= 1.0 + 6.0 * (wi - min)/(max - min) 
dietout1= subset(Final,Diet==1 & Out==1) #Here we have to create the 
subsample we are working on to just plot the observed values of that below 
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size, 
xlab = "Number of Weeks",  #Plotting here the observed values of the subsample 
     ylab = "Waist Circumference Effect Size (d)", xlim=c(0, 208), ylim=c(-3, 0.5)) 
lines(seq(0,208,.1), model21pred$pred, col = "dark red")                                     
#Plotting here the regression line and confidence interval of the predictive model 
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lines(seq(0,208,.1), model21pred$ci.lb, lty = "dashed", col="dark red") 
lines(seq(0,208,.1), model21pred$ci.ub, lty = "dashed", col="dark red") 
model21<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods = Weeks, 
data=Final, method="REML", slab= paste(Reference, Year, sep =",")) 
model21pred <- predict(model21, newmods=cbind(seq(0,208,.1))) 
model21 
 
model61<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=Weeks, 
data=Final, method="REML", slab= paste(Reference, Year, sep =",")) 
model61pred <- predict(model61, newmods=cbind(seq(0,208,.1))) 
wi = Final$w_d.ex. 
min= min(wi, na.rm=TRUE) 
max= max(wi, na.rm=TRUE) 
size= 1.0 + 6.0 * (wi - min)/(max - min) 
dietout1= subset(Final,Diet==1 & Out==3) #Here we have to create the 
subsample we are working on to just plot the observed values of that below 
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size, 
xlab = "Number of Weeks",  #Plotting here the observed values of the subsample 
     ylab = "HDL Effect Size (d)",xlim=c(0, 208), ylim=c(-1.5, 1.5)) 
lines(seq(0,208,.1), model61pred$pred, col = "dark red")                                     
#Plotting here the regression line and confidence interval of the predictive model 
lines(seq(0,208,.1), model61pred$ci.lb, lty = "dashed", col="dark red") 
lines(seq(0,208,.1), model61pred$ci.ub, lty = "dashed", col="dark red") 
model61 
 
model81<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=Weeks, 
data=Final, method="REML", slab= paste(Reference, Year, sep =",")) 
model81pred <- predict(model81, newmods=cbind(seq(0,208,.1))) 
wi = Final$w_d.ex. 
min= min(wi, na.rm=TRUE) 
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max= max(wi, na.rm=TRUE) 
size= 1.0 + 6.0 * (wi - min)/(max - min) 
dietout1= subset(Final,Diet==1 & Out==4) #Here we have to create the 
subsample we are working on to just plot the observed values of that below 
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size, 
xlab = "Number of Weeks",  #Plotting here the observed values of the subsample 
     ylab = "Triglycerides Effect Size (d)",xlim=c(0, 208), ylim=c(-3, 0.5)) 
lines(seq(0,208,.1), model81pred$pred, col = "dark red")                                     
#Plotting here the regression line and confidence interval of the predictive model 
lines(seq(0,208,.1), model81pred$ci.lb, lty = "dashed", col="dark red") 
lines(seq(0,208,.1), model81pred$ci.ub, lty = "dashed", col="dark red") 
model81 
 
model101<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=Weeks, 
data=Final, method="REML", slab= paste(Reference, Year, sep =",")) 
model101pred <- predict(model101, newmods=cbind(seq(0,208,.1))) 
wi = Final$w_d.ex. 
min= min(wi, na.rm=TRUE) 
max= max(wi, na.rm=TRUE) 
size= 1.0 + 6.0 * (wi - min)/(max - min) 
dietout1= subset(Final,Diet==1 & Out==5) #Here we have to create the 
subsample we are working on to just plot the observed values of that below 
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size, 
xlab = "Number of Weeks",  #Plotting here the observed values of the subsample 
     ylab = "Glucose Effect Size (d)",xlim=c(0, 208), ylim=c(-3, 0.5)) 
lines(seq(0,208,.1), model101pred$pred, col = "dark red")                                     
#Plotting here the regression line and confidence interval of the predictive model 
lines(seq(0,208,.1), model101pred$ci.lb, lty = "dashed", col="dark red") 





model121<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=Weeks, 
data=Final, method="REML", slab= paste(Reference, Year, sep =",")) 
model121pred <- predict(model121, newmods=cbind(seq(0,208,.1))) 
wi = Final$w_d.ex. 
min= min(wi, na.rm=TRUE) 
max= max(wi, na.rm=TRUE) 
size= 1.0 + 6.0 * (wi - min)/(max - min) 
dietout1= subset(Final,Diet==1 & Out==6) #Here we have to create the 
subsample we are working on to just plot the observed values of that below 
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size, 
xlab = "Number of Weeks",  #Plotting here the observed values of the subsample 
     ylab = "Systolic Blood Pressure Effect Size (d)",xlim=c(0, 208), ylim=c(-3, 
0.5)) 
lines(seq(0,208,.1), model121pred$pred, col = "dark red")                                     
#Plotting here the regression line and confidence interval of the predictive model 
lines(seq(0,208,.1), model121pred$ci.lb, lty = "dashed", col="dark red") 
lines(seq(0,208,.1), model121pred$ci.ub, lty = "dashed", col="dark red") 
model121 
model141<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=Weeks, 
data=Final, method="REML", slab= paste(Reference, Year, sep =",")) 
model141pred <- predict(model141, newmods=cbind(seq(0,208,.1))) 
wi = Final$w_d.ex. 
min= min(wi, na.rm=TRUE) 
max= max(wi, na.rm=TRUE) 
size= 1.0 + 6.0 * (wi - min)/(max - min) 
dietout1= subset(Final,Diet==1 & Out==7) #Here we have to create the 
subsample we are working on to just plot the observed values of that below 
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size, 
xlab = "Number of Weeks",  #Plotting here the observed values of the subsample 
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     ylab = "Diastolic Blood Pressure Effect Size (d)",xlim=c(0, 208), ylim=c(-3, 
0.5)) 
lines(seq(0,208,.1), model141pred$pred, col = "dark red")                                     
#Plotting here the regression line and confidence interval of the predictive model 
lines(seq(0,208,.1), model141pred$ci.lb, lty = "dashed", col="dark red") 
lines(seq(0,208,.1), model141pred$ci.ub, lty = "dashed", col="dark red") 
model141 
Moderation for diseasein1_no 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=(diseasein1_no), data=Final, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=(diseasein1_no), data=Final, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=(diseasein1_no), data=Final, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=(diseasein1_no), data=Final, method="REML") 
summary(model556) 
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=(diseasein1_no), data=Final, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=(diseasein1_no), data=Final, method="REML") 
summary(model558) 
Moderation for Year 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=Year, 
data=Final, method="REML") 
summary(model6651) 





model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=Year, 
data=Final, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=Year, 
data=Final, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=Year, 
data=Final, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=Year, 
data=Final, method="REML") 
summary(model6657) 
Moderation for Score 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=score, 
data=Final, method="REML") 
summary(model6651) 
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=score, 
data=Final, method="REML") 
summary(model6653) 
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=score, 
data=Final, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=score, 
data=Final, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=score, 
data=Final, method="REML") 
summary(model6656) 





Moderation for No_FEMin1 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=No_FEMin1, data=MetRisk, method="REML") 
summary(model6651) 
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=No_FEMin1, data=MetRisk, method="REML") 
summary(model6653) 
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=No_FEMin1, data=MetRisk, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=No_FEMin1, data=MetRisk, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=No_FEMin1, data=MetRisk, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=No_FEMin1, data=MetRisk, method="REML") 
summary(model6657) 
Moderation for Prop_FEMin1 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=Prop_FEMin1, data=MetRisk, method="REML") 
summary(model6651) 
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=Prop_FEMin1, data=MetRisk, method="REML") 
summary(model6653) 
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=Prop_FEMin1, data=MetRisk, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=Prop_FEMin1, data=MetRisk, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=Prop_FEMin1, data=MetRisk, method="REML") 
summary(model6657) 
Moderation for n_in1 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=n_in1, 
data=Final, method="REML") 
summary(model6651) 
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=n_in1, 
data=Final, method="REML") 
summary(model6653) 
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=n_in1, 
data=Final, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=n_in1, 
data=Final, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=n_in1, 
data=Final, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=n_in1, 
data=Final, method="REML") 
summary(model6657) 
Moderation for n_total 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=n_total, 
data=MetRisk, method="REML") 
summary(model6651) 





model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=n_total, 
data=MetRisk, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=n_total, 
data=MetRisk, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=n_total, 
data=MetRisk, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=n_total, 
data=MetRisk, method="REML") 
summary(model6657) 
Moderation for agein1 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=agein1, 
data=Final, method="REML") 
summary(model6651) 
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=agein1, 
data=Final, method="REML") 
summary(model6653) 
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=agein1, 
data=Final, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=agein1, 
data=Final, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=agein1, 
data=Final, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=agein1, 
data=Final, method="REML") 
summary(model6657) 
Moderation for disease_in1 prop 
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model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=diseasein1_prop, data=Final, method="REML") 
summary(model6651) 
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=diseasein1_prop, data=Final, method="REML") 
summary(model6653) 
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=diseasein1_prop, data=Final, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=diseasein1_prop, data=Final, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=diseasein1_prop, data=Final, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=diseasein1_prop, data=Final, method="REML") 
summary(model6657) 
Moderation for diseasein1_no 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=diseasein1_no, data=Final, method="REML") 
summary(model6651) 
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=diseasein1_no, data=Final, method="REML") 
summary(model6653) 
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=diseasein1_no, data=Final, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=diseasein1_no, data=Final, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=diseasein1_no, data=Final, method="REML") 
summary(model6657) 
Moderation for medin1_prop 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=medin1_prop, data=MetRisk, method="REML") 
summary(model6651) 
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=medin1_prop, data=MetRisk, method="REML") 
summary(model6653) 
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=medin1_prop, data=MetRisk, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=medin1_prop, data=MetRisk, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=medin1_prop, data=MetRisk, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=medin1_prop, data=MetRisk, method="REML") 
summary(model6657) 
 
Moderation for medin1_no 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=medin1_no, 
data=MetRisk, method="REML") 
summary(model6651) 





model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=medin1_no, 
data=MetRisk, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=medin1_no, 
data=MetRisk, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=medin1_no, 
data=MetRisk, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=medin1_no, 
data=MetRisk, method="REML") 
summary(model6657) 
Moderation for kcaltot_in1 
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=kcaltot_in1, 
data=MetRisk, method="REML") 
summary(model6651) 
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=kcaltot_in1, 
data=MetRisk, method="REML") 
summary(model6653) 
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=kcaltot_in1, 
data=MetRisk, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=kcaltot_in1, 
data=MetRisk, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=kcaltot_in1, 
data=MetRisk, method="REML") 
summary(model6656) 






model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=propcho_in1, data=Final, method="REML") 
summary(model6651) 
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=propcho_in1, data=Final, method="REML") 
summary(model6653) 
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=propcho_in1, data=Final, method="REML") 
summary(model6654) 
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=propcho_in1, data=Final, method="REML") 
summary(model6655) 
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=propcho_in1, data=Final, method="REML") 
summary(model6656) 
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=propcho_in1, data=Final, method="REML") 
summary(model6657) 
Moderator for Region 1 and Region 4 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 & 
(region==1|region==4)), mods=~factor(region), data=Final, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3 & 
(region==1|region==4)), mods=~factor(region), data=Final, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4 & 
(region==1|region==4)), mods=~factor(region), data=Final, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5 & 




model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6 & 
(region==1|region==4)), mods=~factor(region), data=Final, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7 & 
(region==1|region==4)), mods=~factor(region), data=Final, method="REML") 
summary(model558) 
Moderation for disease_in1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(disease_in1), data=Final, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(disease_in1), data=Final, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(disease_in1), data=Final, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(disease_in1), data=Final, method="REML") 
summary(model556) 
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(disease_in1), data=Final, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(disease_in1), data=Final, method="REML") 
summary(model558) 
Moderation for Supple_in1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(Supple_in1), data=Final, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 




model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(Supple_in1), data=Final, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(Supple_in1), data=Final, method="REML") 
summary(model556) 
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(Supple_in1), data=Final, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(Supple_in1), data=Final, method="REML") 
summary(model558) 
Moderation for alcohol_in1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(alcohol_in1), data=Final, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(alcohol_in1), data=Final, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(alcohol_in1), data=Final, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(alcohol_in1), data=Final, method="REML") 
summary(model556) 
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(alcohol_in1), data=Final, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(alcohol_in1), data=Final, method="REML") 
summary(model558) 
Moderation for oc_in1 
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model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(oc_in1), data=Final, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(oc_in1), data=Final, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(oc_in1), data=Final, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(oc_in1), data=Final, method="REML") 
summary(model556) 
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(oc_in1), data=Final, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(oc_in1), data=Final, method="REML") 
summary(model558) 
Moderation for smoke_in1  
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(smoke_in1), data=Final, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(smoke_in1), data=Final, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(smoke_in1), data=Final, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(smoke_in1), data=Final, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(smoke_in1), data=Final, method="REML") 
summary(model558) 
Moderation for congrp 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(congrp), data=Final, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(congrp), data=Final, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(congrp), data=Final, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(congrp), data=Final, method="REML") 
summary(model556) 
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(congrp), data=Final, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(congrp), data=Final, method="REML") 
summary(model558) 
Moderation for provision_in1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(provision_in1), data=Final, method="REML")  
summary(model553)  
 model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 




 model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(provision_in1), data=Final, method="REML")  
summary(model555)  
 model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(provision_in1), data=Final, method="REML")  
summary(model556)  
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(provision_in1), data=Final, method="REML")  
summary(model557)  
 model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(provision_in1), data=Final, method="REML")  
summary(model558)  
Moderation for macrodist_in1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(macrodist_in1), data=Final, method="REML")  
summary(model553)  
 model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(macrodist_in1), data=Final, method="REML")  
summary(model554)  
 model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(macrodist_in1), data=Final, method="REML")  
summary(model555)  
 model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(macrodist_in1), data=Final, method="REML")  
summary(model556)  
 model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(macrodist_in1), data=Final, method="REML")  
summary(model557)  
 model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(macrodist_in1), data=Final, method="REML")  
summary(model558)  




model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(propcho_in1), data=Final, method="REML")  
 summary(model553)  
 model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(propcho_in1), data=Final, method="REML")  
summary(model554)  
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(propcho_in1), data=Final, method="REML")  
summary(model555)  
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(propcho_in1), data=Final, method="REML")  
summary(model556)  
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(propcho_in1), data=Final, method="REML")  
summary(model557)  
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(propcho_in1), data=Final, method="REML")  
summary(model558)  
Moderation for prop_satfatin1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(propsatfat_in1), data=Final, method="REML")  
summary(model553)  
 model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(propsatfat_in1), data=Final, method="REML")  
summary(model554)  
 model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(propsatfat_in1), data=Final, method="REML")  
summary(model555)  
 model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(propsatfat_in1), data=Final, method="REML")  
summary(model557)  
 model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(propsatfat_in1), data=Final, method="REML")  
summary(model558)  
Moderation for proptotfat_in1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(proptotfat_in1), data=Final, method="REML")  
summary(model553)  
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(proptotfat_in1), data=Final, method="REML")  
summary(model554)  
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(proptotfat_in1), data=Final, method="REML")  
summary(model555)  
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(proptotfat_in1), data=Final, method="REML")  
summary(model556)  
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(proptotfat_in1), data=Final, method="REML")  
summary(model557)  
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(proptotfat_in1), data=Final, method="REML")  
summary(model558)  
Moderation for proppro_in 1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(proppro_in1), data=Final, method="REML")  
summary(model553)  
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 




model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(proppro_in1), data=Final, method="REML")  
summary(model555)  
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(proppro_in1), data=Final, method="REML")  
summary(model556)  
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(proppro_in1), data=Final, method="REML")  
summary(model557)  
 model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(proppro_in1), data=Final, method="REML")  
summary(model558)  
Moderation for lang 
 
























Moderation for pop 
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model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=~factor(pop)-
1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=~factor(pop)-
1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=~factor(pop)-
1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=~factor(pop)-
1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=~factor(pop)-
1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=~factor(pop)-
1, data=MetRisk, method="REML") 
model998 
Moderation for diet_in1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(diet_in1), data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(diet_in1), data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(diet_in1), data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(diet_in1), data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(diet_in1), data=MetRisk, method="REML") 
model998 
Moderation for Interlvl 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(interlvl), data=Final, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(interlvl), data=Final, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(interlvl), data=Final, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(interlvl), data=Final, method="REML") 
summary(model556) 
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(interlvl), data=Final, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(interlvl), data=Final, method="REML") 
summary(model558) 
Moderation for Region-1 
 



































Moderation for congrp-1 
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(congrp)-1, data=Final, method="REML") 
model53 
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(congrp)-1, data=Final, method="REML") 
model54 
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 




model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(congrp)-1, data=Final, method="REML") 
model56 
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(congrp)-1, data=Final, method="REML") 
model57 
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(congrp)-1, data=Final, method="REML") 
model58 







Moderation for medin1-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(medin1)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(medin1)-1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(medin1)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(medin1)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(medin1)-1, data=MetRisk, method="REML") 
model998 
Moderation for experiment-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(experiment)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(experiment)-1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(experiment)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(experiment)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(experiment)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(experiment)-1, data=MetRisk, method="REML") 
model998 
Moderation for diet_monitor-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 




model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML") 
model998 
Moderation for behave-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(behave)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(behave)-1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(behave)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(behave)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(behave)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(behave)-1, data=MetRisk, method="REML") 
model998 
Moderation for compliance_in1-1 
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model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML") 
model998 
Moderation for measure_ad_in1-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML") 
model998 
Moderation for scale_in1-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(scale_in1)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(scale_in1)-1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(scale_in1)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(scale_in1)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(scale_in1)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(scale_in1)-1, data=MetRisk, method="REML") 
model998 
Moderation for counsel_in1-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 




model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML") 
model998 
Moderation for QoL_in1-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML") 
model998 
Moderation for cho_in1-1 
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model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(cho_in1)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(cho_in1)-1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(cho_in1)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(cho_in1)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(cho_in1)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(cho_in1)-1, data=MetRisk, method="REML") 
model998 
Moderation for satfat_in1-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML") 
model998 
Moderation for totfat_in1-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML") 
model994 
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML") 
model998 
Moderation for pro_in1-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(pro_in1)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 




model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(pro_in1)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(pro_in1)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(pro_in1)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(pro_in1)-1, data=MetRisk, method="REML") 
model998 
Moderation for CVD-1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(CVD)-1, data=MetRisk, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(CVD)-1, data=MetRisk, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(CVD)-1, data=MetRisk, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(CVD)-1, data=MetRisk, method="REML") 
summary(model556) 
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(CVD)-1, data=MetRisk, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(CVD)-1, data=MetRisk, method="REML") 
summary(model558) 
Moderation for DM-1 
 127 
 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), mods=~factor(DM)-
1, data=MetRisk, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=~factor(DM)-
1, data=MetRisk, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=~factor(DM)-
1, data=MetRisk, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=~factor(DM)-
1, data=MetRisk, method="REML") 
summary(model556) 
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=~factor(DM)-
1, data=MetRisk, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=~factor(DM)-
1, data=MetRisk, method="REML") 
summary(model558) 
Moderation for MetS-1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(MetS)-1, data=MetRisk, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(MetS)-1, data=MetRisk, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(MetS)-1, data=MetRisk, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 




model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(MetS)-1, data=MetRisk, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(MetS)-1, data=MetRisk, method="REML") 
summary(model558) 
Moderation for overwtobes-1 
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), 
mods=~factor(overwtobes)-1, data=MetRisk, method="REML") 
summary(model553) 
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 
mods=~factor(overwtobes)-1, data=MetRisk, method="REML") 
summary(model554) 
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(overwtobes)-1, data=MetRisk, method="REML") 
summary(model555) 
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(overwtobes)-1, data=MetRisk, method="REML") 
summary(model556) 
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(overwtobes)-1, data=MetRisk, method="REML") 
summary(model557) 
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 
mods=~factor(overwtobes)-1, data=MetRisk, method="REML") 
summary(model558) 
Moderation for interlvl-1 
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), 
mods=~factor(interlvl)-1, data=MetRisk, method="REML") 
model993 
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), 




model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), 
mods=~factor(interlvl)-1, data=MetRisk, method="REML") 
model995 
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), 
mods=~factor(interlvl)-1, data=MetRisk, method="REML") 
model996 
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), 
mods=~factor(interlvl)-1, data=MetRisk, method="REML") 
model997 
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), 











































model23<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=maxweeks, data=Final, method= 
"REML", slab= paste(Reference, Year, sep =",")) 
model23 
model25<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=minweeks, data=Final, method= 
"REML", slab= paste(Reference, Year, sep =",")) 
model25 
model63<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=maxweeks, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model63 
model65<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=minweeks, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model65 
model83<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=maxweeks, data=Final, method= 




model85<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=minweeks, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model85 
model103<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=maxweeks, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model103 
model105<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=minweeks, data=Final, method= 
"REML",slab= paste(Reference, Year, sep="")) 
model105 
model123<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=maxweeks, data=Final, method= 
"REML",slab= paste(Reference, Year, sep="")) 
model123 
model125<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=minweeks, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model125 
model143<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=maxweeks, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model143 
model145<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=minweeks, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model145 





model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==1), mods=mintot, data=Final, method= 
 132 
 
"REML", slab= paste(Reference, Year, sep="")) 
model107 
model87<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==1), mods=maxtot, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model87 
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=mintot, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model107 
model87<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=maxtot, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model87 
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=mintot, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model107 
model87<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=maxtot, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model87 
model106<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=mintot, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model106 
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=maxtot, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model107 
model126<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=mintot, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model126 
model127<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=maxtot, data=Final, method= 
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"REML", slab= paste(Reference, Year, sep="")) 
model127 
model146<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=mintot, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model146 
model147<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=maxtot, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model147 





model27<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=minsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep =",")) 
model27 
model26<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=maxsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep =",")) 
model26 
model66<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=minsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model66 
model67<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=maxsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model67 
model86<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=minsamp, data=Final, method= 




model87<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=maxsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model87 
model106<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=minsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model106 
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=maxsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model107 
model126<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=minsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model126 
model127<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=maxsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model127 
model146<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=minsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model146 
model147<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=maxsamp, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model147 







model27<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=minage, data=Final, method= 
"REML", slab= paste(Reference, Year, sep =",")) 
model27 
model26<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=maxage, data=Final, method= 
"REML", slab= paste(Reference, Year, sep =",")) 
model26 
model66<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=minage, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model66 
model67<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=maxage, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model67 
model86<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=minage, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model86 
model87<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=maxage, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model87 
model106<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=minage, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model106 
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=maxage, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model107 
model126<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=minage, data=Final, method= 




model127<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=maxage, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model127 
model146<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=minage, data=Final, method= 
"REML",slab= paste(Reference, Year, sep="")) 
model146 
model147<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=maxage, data=Final, method= 
"REML", slab= paste(Reference, Year, sep="")) 
model147 
 
 
 
 
 
